Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	active transmembrane transporter activity	SLC6A18 MFSD2A SLC8A2 SLC8A1 ABCA4 ATP8A1 ABCA13 SLC19A1 SURF1 COX6B1 SLC35E1 CTNS	4.78e-07	477	81	12	GO:0022804
GeneOntologyMolecularFunction	active monoatomic ion transmembrane transporter activity	SLC6A18 MFSD2A SLC8A2 SLC8A1 ATP8A1 SLC19A1 SURF1 COX6B1 CTNS	3.60e-06	301	81	9	GO:0022853
GeneOntologyMolecularFunction	glycerophospholipid flippase activity	MFSD2A ABCA4 ATP8A1	2.27e-05	14	81	3	GO:0140333
GeneOntologyMolecularFunction	flippase activity	MFSD2A ABCA4 ATP8A1	4.20e-05	17	81	3	GO:0140327
GeneOntologyMolecularFunction	glucose-6-phosphatase activity	G6PC2 G6PC1	4.86e-05	3	81	2	GO:0004346
GeneOntologyMolecularFunction	sugar-terminal-phosphatase activity	G6PC2 G6PC1	4.86e-05	3	81	2	GO:0050309
GeneOntologyMolecularFunction	calcium:monoatomic cation antiporter activity involved in regulation of postsynaptic cytosolic calcium ion concentration	SLC8A2 SLC8A1	4.86e-05	3	81	2	GO:1905060
GeneOntologyMolecularFunction	transmembrane transporter activity	SLC6A18 MFSD14A MFSD2A SLC8A2 SLC8A1 ABCA4 ATP8A1 PSG5 ABCA13 SLC19A1 SURF1 COX6B1 SLC35E1 CTNS CNGA4	7.01e-05	1180	81	15	GO:0022857
GeneOntologyMolecularFunction	transporter activity	SLC6A18 MFSD14A MFSD2A SLC8A2 SLC8A1 ABCA4 ATP8A1 PSG5 ABCA13 SLC19A1 SURF1 COX6B1 SLC35E1 CTNS CNGA4	1.87e-04	1289	81	15	GO:0005215
GeneOntologyMolecularFunction	ATPase-coupled intramembrane lipid transporter activity	MFSD2A ABCA4 ATP8A1	1.96e-04	28	81	3	GO:0140326
GeneOntologyMolecularFunction	secondary active transmembrane transporter activity	SLC6A18 MFSD2A SLC8A2 SLC8A1 SLC19A1 SLC35E1 CTNS	2.00e-04	296	81	7	GO:0015291
GeneOntologyMolecularFunction	G protein-coupled acetylcholine receptor activity	CHRM2 CHRM4	3.37e-04	7	81	2	GO:0016907
GeneOntologyMolecularFunction	calcium:sodium antiporter activity	SLC8A2 SLC8A1	7.16e-04	10	81	2	GO:0005432
GeneOntologyMolecularFunction	sugar-phosphatase activity	G6PC2 G6PC1	7.16e-04	10	81	2	GO:0050308
GeneOntologyMolecularFunction	primary active transmembrane transporter activity	ABCA4 ATP8A1 ABCA13 SURF1 COX6B1	7.89e-04	178	81	5	GO:0015399
GeneOntologyMolecularFunction	carbohydrate phosphatase activity	G6PC2 G6PC1	8.73e-04	11	81	2	GO:0019203
GeneOntologyMolecularFunction	intramembrane lipid transporter activity	MFSD2A ABCA4 ATP8A1	1.16e-03	51	81	3	GO:0140303
GeneOntologyMolecularFunction	lipid transporter activity	MFSD2A ABCA4 ATP8A1 PSG5 ABCA13	1.21e-03	196	81	5	GO:0005319
GeneOntologyMolecularFunction	calcium:monoatomic cation antiporter activity	SLC8A2 SLC8A1	1.23e-03	13	81	2	GO:0015368
GeneOntologyMolecularFunction	cytidine deaminase activity	APOBEC3D APOBEC3C	1.23e-03	13	81	2	GO:0004126
GeneOntologyMolecularFunction	G protein-coupled neurotransmitter receptor activity	CHRM2 CHRM4	1.23e-03	13	81	2	GO:0099528
GeneOntologyMolecularFunction	monoatomic ion transmembrane transporter activity	SLC6A18 MFSD2A SLC8A2 SLC8A1 ATP8A1 SLC19A1 SURF1 COX6B1 CTNS CNGA4	1.35e-03	793	81	10	GO:0015075
GeneOntologyMolecularFunction	monoatomic cation transmembrane transporter activity	SLC6A18 MFSD2A SLC8A2 SLC8A1 ATP8A1 SURF1 COX6B1 CTNS CNGA4	1.45e-03	664	81	9	GO:0008324
GeneOntologyMolecularFunction	cytochrome-c oxidase activity	SURF1 COX6B1	1.88e-03	16	81	2	GO:0004129
GeneOntologyMolecularFunction	adenylate cyclase binding	ADCY5 ADCYAP1R1	1.88e-03	16	81	2	GO:0008179
GeneOntologyMolecularFunction	transmembrane receptor protein tyrosine phosphatase activity	PTPRH PTPRO	2.12e-03	17	81	2	GO:0005001
GeneOntologyMolecularFunction	transmembrane receptor protein phosphatase activity	PTPRH PTPRO	2.12e-03	17	81	2	GO:0019198
GeneOntologyMolecularFunction	oxidoreductase activity, acting on a heme group of donors	SURF1 COX6B1	2.38e-03	18	81	2	GO:0016675
GeneOntologyMolecularFunction	antiporter activity	SLC8A2 SLC8A1 SLC19A1 SLC35E1	2.41e-03	138	81	4	GO:0015297
GeneOntologyMolecularFunction	RNA cap binding	IFIT5 NCBP1	3.25e-03	21	81	2	GO:0000339
GeneOntologyMolecularFunction	lipid transmembrane transporter activity	MFSD2A ABCA4 PSG5	3.26e-03	73	81	3	GO:0170055
GeneOntologyMolecularFunction	phospholipid transporter activity	MFSD2A ABCA4 ATP8A1	3.39e-03	74	81	3	GO:0005548
GeneOntologyMolecularFunction	G protein-coupled serotonin receptor activity	CHRM2 CHRM4	3.56e-03	22	81	2	GO:0004993
GeneOntologyMolecularFunction	inorganic cation transmembrane transporter activity	SLC6A18 MFSD2A SLC8A2 SLC8A1 SURF1 COX6B1 CTNS CNGA4	3.88e-03	627	81	8	GO:0022890
GeneOntologyMolecularFunction	acetylcholine receptor activity	CHRM2 CHRM4	3.89e-03	23	81	2	GO:0015464
GeneOntologyMolecularFunction	phosphatidylinositol-5-phosphate binding	JPH2 RS1	3.89e-03	23	81	2	GO:0010314
GeneOntologyMolecularFunction	virus receptor activity	ACE2 DPP4 EGFR	5.00e-03	85	81	3	GO:0001618
GeneOntologyMolecularFunction	exogenous protein binding	ACE2 DPP4 EGFR	5.17e-03	86	81	3	GO:0140272
GeneOntologyMolecularFunction	sodium ion transmembrane transporter activity	SLC6A18 MFSD2A SLC8A2 SLC8A1	5.18e-03	171	81	4	GO:0015081
GeneOntologyMolecularFunction	mannosyltransferase activity	ALG8 ALG12	5.74e-03	28	81	2	GO:0000030
GeneOntologyBiologicalProcess	defense response to virus	APOBEC3D IFIT5 NCBP1 APOBEC3C UNC93B1 PQBP1 IFIT2 LYST IFIT3 CARD8	1.02e-06	342	82	10	GO:0051607
GeneOntologyBiologicalProcess	response to virus	APOBEC3D IFIT5 NCBP1 APOBEC3C UNC93B1 PQBP1 IFIT2 LYST IFIT3 CARD8	7.07e-06	425	82	10	GO:0009615
GeneOntologyBiologicalProcess	receptor-mediated endocytosis of virus by host cell	ACE2 DPP4 KIAA0319L	1.30e-05	12	82	3	GO:0019065
GeneOntologyBiologicalProcess	endocytosis involved in viral entry into host cell	ACE2 DPP4 KIAA0319L	2.14e-05	14	82	3	GO:0075509
GeneOntologyBiologicalProcess	calcium ion transport into cytosol	SLC8A2 SLC8A1 JPH2 ADCYAP1R1	2.31e-05	42	82	4	GO:0060402
GeneOntologyBiologicalProcess	vascular process in circulatory system	ACE2 MFSD2A SLC8A2 SLC8A1 ATP8A1 EGFR PSG5 SLC19A1	6.73e-05	344	82	8	GO:0003018
GeneOntologyBiologicalProcess	defense response to other organism	DPP4 APOBEC3D PSG5 SLC19A1 SCD TAX1BP1 IFIT5 NCBP1 APOBEC3C UNC93B1 PQBP1 IFIT2 PGC LYST IFIT3 CARD8	1.15e-04	1407	82	16	GO:0098542
GeneOntologyBiologicalProcess	transport of virus	ACE2 DPP4 KIAA0319L	1.15e-04	24	82	3	GO:0046794
GeneOntologyBiologicalProcess	defense response to symbiont	DPP4 APOBEC3D PSG5 SLC19A1 TAX1BP1 IFIT5 NCBP1 APOBEC3C UNC93B1 PQBP1 IFIT2 PGC LYST IFIT3 CARD8	1.47e-04	1286	82	15	GO:0140546
GeneOntologyBiologicalProcess	circulatory system process	EPHX2 ACE2 MFSD2A SLC8A2 SLC8A1 ATP8A1 EGFR PTPRO PSG5 SLC19A1 CHRM2	1.49e-04	733	82	11	GO:0003013
GeneOntologyBiologicalProcess	regulation of cardiac conduction	ACE2 SLC8A2 SLC8A1	2.05e-04	29	82	3	GO:1903779
GeneOntologyBiologicalProcess	receptor-mediated virion attachment to host cell	ACE2 DPP4	2.32e-04	6	82	2	GO:0046813
GeneOntologyBiologicalProcess	clearance of foreign intracellular DNA	APOBEC3D APOBEC3C	2.32e-04	6	82	2	GO:0044355
GeneOntologyBiologicalProcess	clearance of foreign intracellular nucleic acids	APOBEC3D APOBEC3C	2.32e-04	6	82	2	GO:0099046
GeneOntologyBiologicalProcess	carbohydrate derivative metabolic process	ATPSCKMT SPAM1 APOBEC3D FBXO6 ICMT ALG8 FUCA1 APOBEC3C CTNS G6PC2 G6PC1 ALG12 ADCY5 STT3B	3.14e-04	1226	82	14	GO:1901135
GeneOntologyBiologicalProcess	monoatomic cation transmembrane transport	SLC6A18 ATPSCKMT SLC8A2 SLC8A1 ATP8A1 SURF1 COX6B1 JPH2 NIPSNAP2 CTNS CNGA4 ADCYAP1R1	3.33e-04	942	82	12	GO:0098655
GeneOntologyBiologicalProcess	innate immune response	DPP4 APOBEC3D PSG5 SLC19A1 TAX1BP1 IFIT5 APOBEC3C UNC93B1 PQBP1 IFIT2 LYST IFIT3 CARD8	3.55e-04	1092	82	13	GO:0045087
GeneOntologyBiologicalProcess	transport across blood-brain barrier	MFSD2A SLC8A2 ATP8A1 SLC19A1	4.02e-04	87	82	4	GO:0150104
GeneOntologyBiologicalProcess	viral life cycle	ACE2 DPP4 APOBEC3D EGFR KIAA0319L IFIT5 APOBEC3C	4.10e-04	340	82	7	GO:0019058
GeneOntologyBiologicalProcess	vascular transport	MFSD2A SLC8A2 ATP8A1 SLC19A1	4.20e-04	88	82	4	GO:0010232
GeneOntologyBiologicalProcess	adenylate cyclase-inhibiting G protein-coupled acetylcholine receptor signaling pathway	CHRM2 CHRM4	4.30e-04	8	82	2	GO:0007197
GeneOntologyBiologicalProcess	monoatomic ion transmembrane transport	SLC6A18 ATPSCKMT SLC8A2 SLC8A1 ATP8A1 SLC19A1 SURF1 COX6B1 JPH2 NIPSNAP2 CTNS CNGA4 ADCYAP1R1	4.33e-04	1115	82	13	GO:0034220
GeneOntologyBiologicalProcess	organophosphate ester transport	MFSD2A ABCA4 ATP8A1 SLC19A1 G6PC1	4.71e-04	162	82	5	GO:0015748
GeneOntologyBiologicalProcess	virion attachment to host cell	ACE2 DPP4	5.52e-04	9	82	2	GO:0019062
GeneOntologyBiologicalProcess	glycosyl compound catabolic process	APOBEC3D FUCA1 APOBEC3C	5.79e-04	41	82	3	GO:1901658
GeneOntologyBiologicalProcess	glycosyl compound metabolic process	APOBEC3D ICMT FUCA1 APOBEC3C	5.84e-04	96	82	4	GO:1901657
GeneOntologyCellularComponent	symmetric synapse	MKLN1 IGSF9B CHRM2	1.56e-05	13	81	3	GO:0032280
GeneOntologyCellularComponent	cell projection membrane	SLC6A18 ACE2 DPP4 PTPRH EGFR PSG5 SLC19A1 IFIT5 CNGA4	4.35e-05	431	81	9	GO:0031253
GeneOntologyCellularComponent	postsynaptic specialization of symmetric synapse	MKLN1 IGSF9B	8.85e-05	4	81	2	GO:0099629
GeneOntologyCellularComponent	apical part of cell	SLC6A18 ACE2 DPP4 DUOX1 PTPRH EGFR PTPRO PSG5 SLC19A1 IFIT5	9.48e-05	592	81	10	GO:0045177
GeneOntologyCellularComponent	apical plasma membrane	SLC6A18 ACE2 DPP4 DUOX1 PTPRH EGFR PTPRO PSG5 SLC19A1	1.11e-04	487	81	9	GO:0016324
GeneOntologyCellularComponent	postsynaptic membrane	SLC8A2 SLC8A1 PTPRO MKLN1 APBB1 IGSF9B CHRM2 CHRM4	1.73e-04	405	81	8	GO:0045211
GeneOntologyCellularComponent	neuron to neuron synapse	SLC8A2 ZDHHC15 SLC8A1 PTPRO MKLN1 IGSF9B RS1 CHRM2 CHRM4	1.89e-04	523	81	9	GO:0098984
GeneOntologyCellularComponent	endoplasmic reticulum membrane	MFSD2A MBTPS1 EGFR ICMT SCD MACO1 JPH2 ALG8 UNC93B1 G6PC2 G6PC1 ALG12 STT3B	1.34e-03	1293	81	13	GO:0005789
GeneOntologyCellularComponent	endoplasmic reticulum subcompartment	MFSD2A MBTPS1 EGFR ICMT SCD MACO1 JPH2 ALG8 UNC93B1 G6PC2 G6PC1 ALG12 STT3B	1.40e-03	1299	81	13	GO:0098827
GeneOntologyCellularComponent	nuclear outer membrane-endoplasmic reticulum membrane network	MFSD2A MBTPS1 EGFR ICMT SCD MACO1 JPH2 ALG8 UNC93B1 G6PC2 G6PC1 ALG12 STT3B	1.69e-03	1327	81	13	GO:0042175
GeneOntologyCellularComponent	synaptic membrane	SLC8A2 SLC8A1 PTPRO MKLN1 APBB1 IGSF9B CHRM2 CHRM4	1.88e-03	583	81	8	GO:0097060
GeneOntologyCellularComponent	neuron projection terminus	SLC8A2 SLC8A1 MACO1 CHRM2 CHRM4	2.12e-03	233	81	5	GO:0044306
HumanPheno	Hyponatremia	ALG8 UNC93B1 CTNS LYST ALG12	1.53e-05	60	28	5	HP:0002902
HumanPheno	Abnormal blood sodium concentration	ALG8 UNC93B1 CTNS LYST ALG12	3.74e-05	72	28	5	HP:0010931
HumanPheno	Death in childhood	MFSD2A SURF1 JPH2 PQBP1 ADCY5 STT3B	6.10e-05	131	28	6	HP:0003819
MousePheno	abnormal susceptibility to viral infection	ACE2 DPP4 MBTPS1 APOBEC3D EGFR PSG5 KIAA0319L UNC93B1 IFIT2 LYST	5.00e-07	279	64	10	MP:0020185
MousePheno	pigmentation phenotype	ACE2 MFSD2A MBTPS1 ABCA4 EGFR NTRK1 RBPMS2 KIAA0319L MKLN1 ALG8 FUCA1 CTNS RS1 LYST	6.52e-07	624	64	14	MP:0001186
MousePheno	increased susceptibility to viral infection	ACE2 DPP4 MBTPS1 APOBEC3D EGFR UNC93B1 IFIT2 LYST	1.10e-06	172	64	8	MP:0002418
MousePheno	pulmonary hyaline membrane formation	ACE2 DPP4	2.06e-05	2	64	2	MP:0011018
MousePheno	abnormal susceptibility to pulmonary hyaline membrane formation	ACE2 DPP4	2.06e-05	2	64	2	MP:0031106
MousePheno	increased susceptibility to pulmonary hyaline membrane formation	ACE2 DPP4	2.06e-05	2	64	2	MP:0012041
MousePheno	abnormal susceptibility to infection	ACE2 DPP4 MBTPS1 APOBEC3D EGFR PSG5 SCD KIAA0319L UNC93B1 IFIT2 LYST ADCYAP1R1	4.54e-05	672	64	12	MP:0001793
MousePheno	abnormal susceptibility to Coronaviridae infection	ACE2 DPP4 EGFR PSG5	7.25e-05	49	64	4	MP:0020948
MousePheno	abnormal response to infection	ACE2 DPP4 MBTPS1 APOBEC3D EGFR PSG5 SCD KIAA0319L UNC93B1 IFIT2 LYST ADCYAP1R1	8.15e-05	714	64	12	MP:0005025
MousePheno	increased susceptibility to infection	ACE2 DPP4 MBTPS1 APOBEC3D EGFR SCD UNC93B1 IFIT2 LYST ADCYAP1R1	8.93e-05	504	64	10	MP:0002406
MousePheno	abnormal response to antigen	ACE2 DPP4 MBTPS1 APOBEC3D EGFR PSG5 SCD KIAA0319L UNC93B1 IFIT2 LYST ADCYAP1R1	9.55e-05	726	64	12	MP:0020000
MousePheno	increased susceptibility to Riboviria infection induced morbidity/mortality	ACE2 DPP4 EGFR IFIT2	1.23e-04	56	64	4	MP:0031024
MousePheno	decreased susceptibility to infection	ACE2 DPP4 MBTPS1 APOBEC3D PSG5 KIAA0319L LYST	1.58e-04	255	64	7	MP:0002409
MousePheno	increased susceptibility to Coronaviridae infection	ACE2 DPP4 EGFR	1.73e-04	24	64	3	MP:0020949
MousePheno	decreased susceptibility to viral infection	ACE2 DPP4 APOBEC3D PSG5 KIAA0319L	2.64e-04	125	64	5	MP:0002410
MousePheno	decreased susceptibility to Coronaviridae infection	ACE2 DPP4 PSG5	2.76e-04	28	64	3	MP:0020950
MousePheno	abnormal retina pigment epithelium morphology	MFSD2A ABCA4 CTNS RS1 LYST	3.77e-04	135	64	5	MP:0005201
MousePheno	increased susceptibility to viral infection induced morbidity/mortality	ACE2 DPP4 EGFR IFIT2	4.21e-04	77	64	4	MP:0009791
MousePheno	impaired smooth muscle contractility	SLC8A1 CHRM2 CHRM4	5.40e-04	35	64	3	MP:0000740
MousePheno	increased left ventricle systolic pressure	SLC8A1 EGFR	5.68e-04	8	64	2	MP:0003820
Domain	Na_Ca_Ex	SLC8A2 SLC8A1	5.15e-05	3	78	2	IPR004836
Domain	Na_Ca_Ex_C-exten	SLC8A2 SLC8A1	5.15e-05	3	78	2	IPR032452
Domain	Glucose-6-phosphatase	G6PC2 G6PC1	5.15e-05	3	78	2	IPR016275
Domain	Na_Ca_ex_C	SLC8A2 SLC8A1	5.15e-05	3	78	2	PF16494
Domain	Pecanex_C	PCNX3 PCNX1	1.03e-04	4	78	2	PF05041
Domain	Pecanex	PCNX3 PCNX1	1.03e-04	4	78	2	IPR007735
Domain	Musac_Ach_rcpt	CHRM2 CHRM4	1.71e-04	5	78	2	IPR000995
Domain	Calx_beta	SLC8A2 SLC8A1	4.74e-04	8	78	2	SM00237
Domain	Calx_beta	SLC8A2 SLC8A1	6.08e-04	9	78	2	IPR003644
Domain	NaCa_Exmemb	SLC8A2 SLC8A1	6.08e-04	9	78	2	IPR004837
Domain	Na_Ca_ex	SLC8A2 SLC8A1	6.08e-04	9	78	2	PF01699
Domain	PKD/Chitinase_dom	KIAA0319L SORCS1	6.08e-04	9	78	2	IPR022409
Domain	PKD	KIAA0319L SORCS1	6.08e-04	9	78	2	SM00089
Domain	Calx-beta	SLC8A2 SLC8A1	6.08e-04	9	78	2	PF03160
Domain	PKD	KIAA0319L SORCS1	9.24e-04	11	78	2	PS50093
Domain	PKD_dom	KIAA0319L SORCS1	9.24e-04	11	78	2	IPR000601
Domain	-	KIAA0319L SORCS1	9.24e-04	11	78	2	2.60.40.670
Domain	APOBEC_N	APOBEC3D APOBEC3C	1.11e-03	12	78	2	PF08210
Domain	ABC_A	ABCA4 ABCA13	1.11e-03	12	78	2	IPR026082
Domain	APOBEC_N	APOBEC3D APOBEC3C	1.11e-03	12	78	2	IPR013158
Domain	TPR_2	IFIT5 IFIT2 IFIT3	1.19e-03	50	78	3	PF07719
Domain	TPR_2	IFIT5 IFIT2 IFIT3	1.19e-03	50	78	3	IPR013105
Domain	TPR_8	IFIT5 IFIT2 IFIT3	1.41e-03	53	78	3	PF13181
Domain	APOBEC/CMP_deaminase_Zn-bd	APOBEC3D APOBEC3C	1.52e-03	14	78	2	IPR016192
Domain	Cytidine_deaminase-like	APOBEC3D APOBEC3C	2.25e-03	17	78	2	IPR016193
Domain	CYT_DCMP_DEAMINASES_1	APOBEC3D APOBEC3C	2.25e-03	17	78	2	PS00903
Domain	CMP_dCMP_Zn-bd	APOBEC3D APOBEC3C	2.25e-03	17	78	2	IPR002125
Domain	-	G6PC2 G6PC1	2.52e-03	18	78	2	1.20.144.10
Domain	acidPPc	G6PC2 G6PC1	2.52e-03	18	78	2	SM00014
Domain	P_Acid_Pase_2/haloperoxidase	G6PC2 G6PC1	3.12e-03	20	78	2	IPR000326
Domain	PAP2	G6PC2 G6PC1	3.12e-03	20	78	2	PF01569
Domain	-	FBXO6 MKLN1 RS1	3.53e-03	73	78	3	2.60.120.260
Domain	TPR_1	IFIT5 IFIT2 IFIT3	6.34e-03	90	78	3	PF00515
Domain	TPR_1	IFIT5 IFIT2 IFIT3	6.34e-03	90	78	3	IPR001440
Domain	Galactose-bd-like	FBXO6 MKLN1 RS1	7.15e-03	94	78	3	IPR008979
Domain	FN3	PTPRH PTPRO KIAA0319L IGSF9B	7.52e-03	185	78	4	SM00060
Pubmed	Comprehensive analysis of the prognosis and biological significance for IFIT family in skin cutaneous melanoma.	IFIT5 IFIT2 IFIT3	5.04e-08	4	82	3	34763233
Pubmed	The broad-spectrum antiviral functions of IFIT and IFITM proteins.	IFIT5 IFIT2 IFIT3	2.51e-07	6	82	3	23237964
Pubmed	A Novel Purification Procedure for Active Recombinant Human DPP4 and the Inability of DPP4 to Bind SARS-CoV-2.	ACE2 DPP4	5.49e-06	2	82	2	33218025
Pubmed	Targeting DPP4-RBD interactions by sitagliptin and linagliptin delivers a potential host-directed therapy against pan-SARS-CoV-2 infections.	ACE2 DPP4	5.49e-06	2	82	2	37385308
Pubmed	Loss of muscarinic autoreceptor function impairs long-term depression but not long-term potentiation in the striatum.	CHRM2 CHRM4	5.49e-06	2	82	2	18550768
Pubmed	Muscarinic agonist-mediated increases in serum corticosterone levels are abolished in m(2) muscarinic acetylcholine receptor knockout mice.	CHRM2 CHRM4	5.49e-06	2	82	2	12235238
Pubmed	Molecular basis of binding between novel human coronavirus MERS-CoV and its receptor CD26.	ACE2 DPP4	5.49e-06	2	82	2	23831647
Pubmed	Intranasal fusion inhibitory lipopeptide prevents direct-contact SARS-CoV-2 transmission in ferrets.	ACE2 DPP4	5.49e-06	2	82	2	33597220
Pubmed	Modified expression of peripheral blood lymphocyte muscarinic cholinergic receptors in asthmatic children.	CHRM2 CHRM4	5.49e-06	2	82	2	26025056
Pubmed	Roles of Na(+)/Ca(2+) exchanger isoforms NCX1 and NCX2 in motility in mouse ileum.	SLC8A2 SLC8A1	5.49e-06	2	82	2	27411318
Pubmed	Na+/Ca2+ exchanger contributes to stool transport in mice with experimental diarrhea.	SLC8A2 SLC8A1	5.49e-06	2	82	2	27928109
Pubmed	Striatal muscarinic receptors promote activity dependence of dopamine transmission via distinct receptor subtypes on cholinergic interneurons in ventral versus dorsal striatum.	CHRM2 CHRM4	5.49e-06	2	82	2	20203199
Pubmed	Evaluation of muscarinic agonist-induced analgesia in muscarinic acetylcholine receptor knockout mice.	CHRM2 CHRM4	5.49e-06	2	82	2	12391271
Pubmed	Phage-Displayed Mimotopes of SARS-CoV-2 Spike Protein Targeted to Authentic and Alternative Cellular Receptors.	ACE2 DPP4	5.49e-06	2	82	2	35215976
Pubmed	Generation and pharmacological analysis of M2 and M4 muscarinic receptor knockout mice.	CHRM2 CHRM4	5.49e-06	2	82	2	11392613
Pubmed	Characterization of the novel positive allosteric modulator, LY2119620, at the muscarinic M(2) and M(4) receptors.	CHRM2 CHRM4	5.49e-06	2	82	2	24807965
Pubmed	Development of a radioligand, [(3)H]LY2119620, to probe the human M(2) and M(4) muscarinic receptor allosteric binding sites.	CHRM2 CHRM4	5.49e-06	2	82	2	24807966
Pubmed	Cloning and characterization of the human and rat islet-specific glucose-6-phosphatase catalytic subunit-related protein (IGRP) genes.	G6PC2 G6PC1	5.49e-06	2	82	2	11297555
Pubmed	Genetic knockout and pharmacologic inhibition of NCX2 cause natriuresis and hypercalciuria.	SLC8A2 SLC8A1	5.49e-06	2	82	2	25498502
Pubmed	Stearoyl-CoA desaturase activity modulates the activation of epidermal growth factor receptor in human lung cancer cells.	EGFR SCD	5.49e-06	2	82	2	22946088
Pubmed	Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B betacoronaviruses.	ACE2 DPP4	5.49e-06	2	82	2	32094589
Pubmed	Dysregulated hippocampal acetylcholine neurotransmission and impaired cognition in M2, M4 and M2/M4 muscarinic receptor knockout mice.	CHRM2 CHRM4	5.49e-06	2	82	2	12874603
Pubmed	Structural and Functional Basis of SARS-CoV-2 Entry by Using Human ACE2.	ACE2 DPP4	5.49e-06	2	82	2	32275855
Pubmed	Muscarinic M2 receptors on peripheral nerve endings: a molecular target of antinociception.	CHRM2 CHRM4	5.49e-06	2	82	2	12045234
Pubmed	Opposing functions of spinal M2, M3, and M4 receptor subtypes in regulation of GABAergic inputs to dorsal horn neurons revealed by muscarinic receptor knockout mice.	CHRM2 CHRM4	5.49e-06	2	82	2	16365281
Pubmed	Structural Basis for Potent Neutralization of Betacoronaviruses by Single-Domain Camelid Antibodies.	ACE2 DPP4	5.49e-06	2	82	2	32375025
Pubmed	The lethal internal face of the coronaviruses: Kidney tropism of the SARS, MERS, and COVID19 viruses.	ACE2 DPP4	5.49e-06	2	82	2	34118117
Pubmed	Na(+) /Ca(2+) exchanger-heterozygote knockout mice display increased relaxation in gastric fundus and accelerated gastric transit in vivo.	SLC8A2 SLC8A1	5.49e-06	2	82	2	26787195
Pubmed	M(2) and M(4) receptor knockout mice: muscarinic receptor function in cardiac and smooth muscle in vitro.	CHRM2 CHRM4	5.49e-06	2	82	2	10688600
Pubmed	Elevated phosphorylation of EGFR in NSCLC due to mutations in PTPRH.	PTPRH EGFR	5.49e-06	2	82	2	36054194
Pubmed	The Firing of Theta State-Related Septal Cholinergic Neurons Disrupt Hippocampal Ripple Oscillations via Muscarinic Receptors.	CHRM2 CHRM4	5.49e-06	2	82	2	32265261
Pubmed	Characterization of the receptor-binding domain (RBD) of 2019 novel coronavirus: implication for development of RBD protein as a viral attachment inhibitor and vaccine.	ACE2 DPP4	5.49e-06	2	82	2	32203189
Pubmed	Characterization of central inhibitory muscarinic autoreceptors by the use of muscarinic acetylcholine receptor knock-out mice.	CHRM2 CHRM4	5.49e-06	2	82	2	11880500
Pubmed	Downregulating CD26/DPPIV by apigenin modulates the interplay between Akt and Snail/Slug signaling to restrain metastasis of lung cancer with multiple EGFR statuses.	DPP4 EGFR	5.49e-06	2	82	2	30134935
Pubmed	A genetic variant of G6PC2 is associated with type 2 diabetes and fasting plasma glucose level in the Chinese population.	G6PC2 G6PC1	5.49e-06	2	82	2	19082990
Pubmed	Putative Receptor Binding Domain of Bat-Derived Coronavirus HKU9 Spike Protein: Evolution of Betacoronavirus Receptor Binding Motifs.	ACE2 DPP4	5.49e-06	2	82	2	27696819
Pubmed	Intronic variant of EGFR is associated with GBAS expression and survival outcome of early-stage non-small cell lung cancer.	EGFR NIPSNAP2	5.49e-06	2	82	2	29806744
Pubmed	Knockouts reveal overlapping functions of M(2) and M(4) muscarinic receptors and evidence for a local glutamatergic circuit within the laterodorsal tegmental nucleus.	CHRM2 CHRM4	5.49e-06	2	82	2	22956788
Pubmed	Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC.	ACE2 DPP4	5.49e-06	2	82	2	23486063
Pubmed	Effects of induced Na+/Ca2+ exchanger overexpression on the spatial distribution of L-type Ca2+ channels and junctophilin-2 in pressure-overloaded hearts.	SLC8A1 JPH2	5.49e-06	2	82	2	27789286
Pubmed	HIV-1 Vpr induces interferon-stimulated genes in human monocyte-derived macrophages.	APOBEC3C IFIT2 IFIT3	5.63e-06	15	82	3	25170834
Pubmed	Interrogating the protein interactomes of RAS isoforms identifies PIP5K1A as a KRAS-specific vulnerability.	FAM171A2 EGFR SLC19A1 SCD KIAA0319L SLC35E1 APBB1 STT3B	1.49e-05	467	82	8	30194290
Pubmed	The NADPH Oxidases DUOX1 and NOX2 Play Distinct Roles in Redox Regulation of Epidermal Growth Factor Receptor Signaling.	DUOX1 EGFR	1.64e-05	3	82	2	27650496
Pubmed	G6PC indicated poor prognosis in cervical cancer and promoted cervical carcinogenesis in vitro and in vivo.	G6PC2 G6PC1	1.64e-05	3	82	2	35277194
Pubmed	Muscarinic M2 receptors mediate transactivation of EGF receptor through Fyn kinase and without matrix metalloproteases.	EGFR CHRM2	1.64e-05	3	82	2	16337776
Pubmed	Functional annotation of heart enriched mitochondrial genes GBAS and CHCHD10 through guilt by association.	SURF1 NIPSNAP2	1.64e-05	3	82	2	20888800
Pubmed	Epidermal growth factor-induced hydrogen peroxide production is mediated by dual oxidase 1.	DUOX1 EGFR	1.64e-05	3	82	2	27262981
Pubmed	Expression analysis of miRNA hsa-let7b-5p in naso-oropharyngeal swabs of COVID-19 patients supports its role in regulating ACE2 and DPP4 receptors.	ACE2 DPP4	1.64e-05	3	82	2	36073344
Pubmed	The APOBEC3C crystal structure and the interface for HIV-1 Vif binding.	APOBEC3D APOBEC3C	1.64e-05	3	82	2	23001005
Pubmed	Nerve growth factor (NGF)-TrkA axis in head and neck squamous cell carcinoma triggers EMT and confers resistance to the EGFR inhibitor erlotinib.	EGFR NTRK1	1.64e-05	3	82	2	31838083
Pubmed	The interferon stimulated gene 54 promotes apoptosis.	IFIT2 IFIT3	1.64e-05	3	82	2	21190939
Pubmed	Effects of muscarinic receptor antagonists on cocaine discrimination in wild-type mice and in muscarinic receptor M1, M2, and M4 receptor knockout mice.	CHRM2 CHRM4	1.64e-05	3	82	2	28442355
Pubmed	G6PC1 and G6PC2 influence G6P flux but not HSD11B1 activity.	G6PC2 G6PC1	1.64e-05	3	82	2	37855366
Pubmed	High levels of synaptosomal Na(+)-Ca(2+) exchangers (NCX1, NCX2, NCX3) co-localized with amyloid-beta in human cerebral cortex affected by Alzheimer's disease.	SLC8A2 SLC8A1	1.64e-05	3	82	2	21382638
Pubmed	Group II muscarinic acetylcholine receptors attenuate hepatic injury via Nrf2/ARE pathway.	CHRM2 CHRM4	1.64e-05	3	82	2	32234387
Pubmed	M2 and M3 muscarinic receptors are involved in enteric nerve-mediated contraction of the mouse ileum: Findings obtained with muscarinic-receptor knockout mouse.	CHRM2 CHRM4	1.64e-05	3	82	2	17008557
Pubmed	Interferon-stimulated gene (ISG) 60, as well as ISG56 and ISG54, positively regulates TLR3/IFN-β/STAT1 axis in U373MG human astrocytoma cells.	IFIT2 IFIT3	1.64e-05	3	82	2	26423178
Pubmed	Molecular cloning and characterization of a murine LPS-inducible cDNA.	IFIT2 IFIT3	1.64e-05	3	82	2	8207206
Pubmed	The downregulation of NCXs is positively correlated with the prognosis of stage II-IV colon cancer.	SLC8A2 SLC8A1	1.64e-05	3	82	2	34127021
Pubmed	Orphan transporter SLC6A18 is renal neutral amino acid transporter B0AT3.	SLC6A18 ACE2	1.64e-05	3	82	2	19478081
Pubmed	GRK5 deficiency leads to reduced hippocampal acetylcholine level via impaired presynaptic M2/M4 autoreceptor desensitization.	CHRM2 CHRM4	1.64e-05	3	82	2	19478075
Pubmed	Characterization of the phosphotyrosine-binding domain of the Drosophila Shc protein.	EGFR NTRK1	1.64e-05	3	82	2	8943228
Pubmed	PACAP through EGFR transactivation preserves human corneal endothelial integrity.	EGFR ADCYAP1R1	1.64e-05	3	82	2	30548314
Pubmed	Genetic deletion of CB1 receptors improves non-associative learning.	CHRM2 CHRM4	1.64e-05	3	82	2	15922076
Pubmed	Dual oxidase-1 is required for airway epithelial cell migration and bronchiolar reepithelialization after injury.	DUOX1 EGFR	1.64e-05	3	82	2	23239498
Pubmed	Structure-Dynamic Coupling Through Ca2+-Binding Regulatory Domains of Mammalian NCX Isoform/Splice Variants.	SLC8A2 SLC8A1	1.64e-05	3	82	2	29594857
Pubmed	Assignment of muscarinic receptor subtypes mediating G-protein modulation of Ca(2+) channels by using knockout mice.	CHRM2 CHRM4	1.64e-05	3	82	2	10485923
Pubmed	EGFR modulates monounsaturated fatty acid synthesis through phosphorylation of SCD1 in lung cancer.	EGFR SCD	1.64e-05	3	82	2	28724430
Pubmed	IFIT3 and IFIT2/3 promote IFIT1-mediated translation inhibition by enhancing binding to non-self RNA.	IFIT2 IFIT3	1.64e-05	3	82	2	29554348
Pubmed	Distribution of ACE2, CD147, CD26, and other SARS-CoV-2 associated molecules in tissues and immune cells in health and in asthma, COPD, obesity, hypertension, and COVID-19 risk factors.	ACE2 DPP4	1.64e-05	3	82	2	32496587
Pubmed	Muscarinic receptor knockout mice: role of muscarinic acetylcholine receptors M(2), M(3), and M(4) in carbamylcholine-induced gallbladder contractility.	CHRM2 CHRM4	1.64e-05	3	82	2	11961069
Pubmed	SARS-CoV-2 uses metabotropic glutamate receptor subtype 2 as an internalization factor to infect cells.	ACE2 DPP4	1.64e-05	3	82	2	34903715
Pubmed	Identification of specific determinants of human APOBEC3F, APOBEC3C, and APOBEC3DE and African green monkey APOBEC3F that interact with HIV-1 Vif.	APOBEC3D APOBEC3C	1.64e-05	3	82	2	20943965
Pubmed	A conserved amino-terminal Shc domain binds to phosphotyrosine motifs in activated receptors and phosphopeptides.	EGFR NTRK1	1.64e-05	3	82	2	7542991
Pubmed	Aberrant Amygdala-Dependent Cued Fear Memory in Na+/Ca2+ Exchanger 1 Heterozygous Mice.	SLC8A2 SLC8A1	1.64e-05	3	82	2	30324228
Pubmed	Sodium-calcium exchange in intracellular calcium handling of human airway smooth muscle.	SLC8A2 SLC8A1	1.64e-05	3	82	2	21858195
Pubmed	Intact coupling of M1 receptors and preserved M2 and M4 receptors in the cortex in progressive supranuclear palsy: contrast with other dementias.	CHRM2 CHRM4	1.64e-05	3	82	2	18282687
Pubmed	IFIT1 and IFIT3 promote oral squamous cell carcinoma metastasis and contribute to the anti-tumor effect of gefitinib via enhancing p-EGFR recycling.	EGFR IFIT3	1.64e-05	3	82	2	30626937
Pubmed	Knowledge-based analysis of functional impacts of mutations in microRNA seed regions.	EGFR NTRK1	1.64e-05	3	82	2	26564979
Pubmed	Paradoxical sleep in mice lacking M3 and M2/M4 muscarinic receptors.	CHRM2 CHRM4	1.64e-05	3	82	2	16110248
Pubmed	Identification of residues that control specific binding of the Shc phosphotyrosine-binding domain to phosphotyrosine sites.	EGFR NTRK1	1.64e-05	3	82	2	8577769
Pubmed	Complement opsonization of HIV-1 results in decreased antiviral and inflammatory responses in immature dendritic cells via CR3.	IFIT2 IFIT3	1.64e-05	3	82	2	25252956
Pubmed	Control of glycinergic input to spinal dorsal horn neurons by distinct muscarinic receptor subtypes revealed using knockout mice.	CHRM2 CHRM4	1.64e-05	3	82	2	17878406
Pubmed	Immunosuppressive drugs, immunophilins, and functional expression of NCX isoforms.	SLC8A2 SLC8A1	1.64e-05	3	82	2	23224887
Pubmed	New roles of NCX in glial cells: activation of microglia in ischemia and differentiation of oligodendrocytes.	SLC8A2 SLC8A1	1.64e-05	3	82	2	23224890
Pubmed	Genetically modified mice as a strategy to unravel the role played by the Na(+)/Ca (2+) exchanger in brain ischemia and in spatial learning and memory deficits.	SLC8A2 SLC8A1	1.64e-05	3	82	2	23224882
Pubmed	Three Na+/Ca2+ exchanger (NCX) variants are expressed in mouse osteoclasts and mediate calcium transport during bone resorption.	SLC8A2 SLC8A1	1.64e-05	3	82	2	17317768
Pubmed	Distinct mixtures of muscarinic receptor subtypes mediate inhibition of noradrenaline release in different mouse peripheral tissues, as studied with receptor knockout mice.	CHRM2 CHRM4	1.64e-05	3	82	2	15965496
Pubmed	Identified Three Interferon Induced Proteins as Novel Biomarkers of Human Ischemic Cardiomyopathy.	IFIT2 IFIT3	1.64e-05	3	82	2	34884921
Pubmed	BRCA2, EGFR, and NTRK mutations in mismatch repair-deficient colorectal cancers with MSH2 or MLH1 mutations.	EGFR NTRK1	1.64e-05	3	82	2	28591715
Pubmed	Interactome and Proteome Dynamics Uncover Immune Modulatory Associations of the Pathogen Sensing Factor cGAS.	APOBEC3D TAX1BP1 HELZ2 APOBEC3C IFIT2 IFIT3	1.72e-05	228	82	6	30471916
Pubmed	Ultrasonic vocalizations induced by sex and amphetamine in M2, M4, M5 muscarinic and D2 dopamine receptor knockout mice.	CHRM2 CHRM4	3.28e-05	4	82	2	18382674
Pubmed	Distinct determinants in HIV-1 Vif and human APOBEC3 proteins are required for the suppression of diverse host anti-viral proteins.	APOBEC3D APOBEC3C	3.28e-05	4	82	2	19088851
Pubmed	Importance of K+-dependent Na+/Ca2+-exchanger 2, NCKX2, in motor learning and memory.	SLC8A2 SLC8A1	3.28e-05	4	82	2	16407245
Pubmed	Expression of PTPRO during mouse development suggests involvement in axonogenesis and differentiation of NT-3 and NGF-dependent neurons.	PTPRO NTRK1	3.28e-05	4	82	2	12532410
Pubmed	Reduced expression of Na+/Ca2+ exchangers is associated with cognitive deficits seen in Alzheimer's disease model mice.	SLC8A2 SLC8A1	3.28e-05	4	82	2	29274751
Pubmed	Coordinated regulation and widespread cellular expression of interferon-stimulated genes (ISG) ISG-49, ISG-54, and ISG-56 in the central nervous system after infection with distinct viruses.	IFIT2 IFIT3	3.28e-05	4	82	2	17079283
Pubmed	Acetylcholine analogue stimulates DNA synthesis in brain-derived cells via specific muscarinic receptor subtypes.	CHRM2 CHRM4	3.28e-05	4	82	2	2739737
Pubmed	Use of differential display analysis to assess the effect of human cytomegalovirus infection on the accumulation of cellular RNAs: induction of interferon-responsive RNAs.	IFIT2 IFIT3	3.28e-05	4	82	2	9391139
Pubmed	A patch of positively charged amino acids surrounding the human immunodeficiency virus type 1 Vif SLVx4Yx9Y motif influences its interaction with APOBEC3G.	APOBEC3D APOBEC3C	3.28e-05	4	82	2	19535450
Interaction	DDOST interactions	ACE2 DPP4 FBXO6 PTPRH EGFR PTPRO SCD NTRK1 APBB1 UNC93B1 STT3B	2.33e-07	375	79	11	int:DDOST
Interaction	ALG1 interactions	ACE2 DPP4 FBXO6 EGFR NTRK1	2.22e-06	54	79	5	int:ALG1
Interaction	XPOT interactions	ACE2 DPP4 FBXO6 PTPRH EGFR PTPRO NTRK1 UNC93B1	2.38e-06	220	79	8	int:XPOT
Interaction	TFRC interactions	ACE2 DPP4 FBXO6 PTPRH EGFR PTPRO NTRK1 KIAA0319L APBB1 UNC93B1 ADCY5	3.13e-06	489	79	11	int:TFRC
Interaction	CANX interactions	ACE2 DPP4 MBTPS1 FBXO6 PTPRH EGFR HLA-DMB ICMT PTPRO SLC19A1 NTRK1 MACO1 KIAA0319L NIPSNAP2 APOBEC3C UNC93B1 STT3B	6.12e-06	1261	79	17	int:CANX
Interaction	GCN1 interactions	ACE2 FBXO6 PTPRH EGFR NTRK1 STK32B NCBP1 UNC93B1 CHRM4	8.95e-06	349	79	9	int:GCN1
Interaction	RPN2 interactions	ACE2 DPP4 ABCA4 FBXO6 EGFR PTPRO SCD NTRK1 MACO1 APBB1 ALG8 UNC93B1 STT3B	1.01e-05	782	79	13	int:RPN2
Interaction	GANAB interactions	ACE2 DPP4 ZDHHC15 FBXO6 PTPRH EGFR PTPRO NTRK1 NIPSNAP2	1.37e-05	368	79	9	int:GANAB
Interaction	HSD17B12 interactions	ACE2 DPP4 EGFR SCD NTRK1 TAX1BP1 UNC93B1	2.50e-05	220	79	7	int:HSD17B12
Interaction	CSE1L interactions	ACE2 DPP4 FBXO6 PTPRH EGFR NTRK1 UNC93B1 UBFD1	3.17e-05	314	79	8	int:CSE1L
Interaction	ARL13B interactions	ACE2 ZDHHC15 FAM171A2 PTPRH EGFR ICMT APBB1 TMEM254	3.47e-05	318	79	8	int:ARL13B
Interaction	UGGT1 interactions	DPP4 FBXO6 PTPRH EGFR PTPRO NTRK1 UNC93B1	3.81e-05	235	79	7	int:UGGT1
Interaction	ATP1B1 interactions	EGFR NTRK1 COX6B1 KIAA0319L NIPSNAP2 UNC93B1	4.99e-05	167	79	6	int:ATP1B1
Interaction	PTK7 interactions	ACE2 DPP4 FAM171A2 PTPRO NTRK1 APBB1	5.16e-05	168	79	6	int:PTK7
Interaction	DNAJB12 interactions	EGFR PTPRO NTRK1 UNC93B1 CNGA4 STT3B	6.27e-05	174	79	6	int:DNAJB12
Interaction	NUP210 interactions	DPP4 FBXO6 EGFR PTPRO NTRK1 UNC93B1	6.27e-05	174	79	6	int:NUP210
Interaction	TTC27 interactions	FBXO6 EGFR SCD NTRK1 UNC93B1	6.33e-05	107	79	5	int:TTC27
Interaction	CCDC47 interactions	DPP4 EGFR ICMT SCD NTRK1 MACO1 ALG8 UNC93B1 STT3B	6.35e-05	448	79	9	int:CCDC47
Interaction	CPD interactions	ACE2 DPP4 FBXO6 EGFR PTPRO NTRK1	6.47e-05	175	79	6	int:CPD
Interaction	STT3B interactions	DPP4 FBXO6 SCD NTRK1 APBB1 UNC93B1 STT3B	6.54e-05	256	79	7	int:STT3B
Interaction	DNAJB11 interactions	ACE2 DPP4 FBXO6 PTPRH EGFR PTPRO NTRK1 STT3B	6.96e-05	351	79	8	int:DNAJB11
Interaction	DNAJC10 interactions	DPP4 FBXO6 EGFR PTPRO NTRK1 UNC93B1 STT3B	7.21e-05	260	79	7	int:DNAJC10
Interaction	STT3A interactions	ACE2 FBXO6 EGFR NTRK1 UNC93B1 STT3B	7.34e-05	179	79	6	int:STT3A
Interaction	RPN1 interactions	ACE2 DPP4 FBXO6 EGFR ICMT SCD NTRK1 MACO1 APBB1 NIPSNAP2 UNC93B1 STT3B	7.39e-05	814	79	12	int:RPN1
Interaction	LANCL1 interactions	ACE2 DPP4 PTPRH EGFR NTRK1	7.87e-05	112	79	5	int:LANCL1
Interaction	MUC6 interactions	ZDHHC15 EGFR	9.06e-05	4	79	2	int:MUC6
Interaction	CKAP4 interactions	ACE2 DPP4 PTPRH EGFR SCD NTRK1 MACO1 APBB1 UNC93B1 STT3B	1.03e-04	592	79	10	int:CKAP4
Interaction	SLC3A2 interactions	ACE2 DPP4 FBXO6 PTPRH EGFR PTPRO NTRK1 NIPSNAP2	1.04e-04	372	79	8	int:SLC3A2
Interaction	SDF2 interactions	DPP4 EGFR PTPRO ZER1	1.09e-04	63	79	4	int:SDF2
Interaction	PGRMC1 interactions	ACE2 DPP4 EGFR PTPRO SCD NIPSNAP2 UNC93B1 STT3B	1.10e-04	375	79	8	int:PGRMC1
Interaction	SNRPA interactions	ACE2 EGFR NTRK1 RBPMS2 NCBP1 APOBEC3C PQBP1 IFIT2 IFIT3	1.11e-04	482	79	9	int:SNRPA
Interaction	RAB5C interactions	ACE2 SLC19A1 NTRK1 MACO1 TAX1BP1 COX6B1 KIAA0319L SLC35E1 APBB1 STT3B	1.15e-04	600	79	10	int:RAB5C
Interaction	TM9SF2 interactions	ACE2 EGFR TAX1BP1 UNC93B1	1.23e-04	65	79	4	int:TM9SF2
Interaction	RAB11FIP1 interactions	ACE2 PTPRH EGFR NTRK1 TAX1BP1	1.32e-04	125	79	5	int:RAB11FIP1
Interaction	HLA-A interactions	ACE2 DPP4 EGFR PTPRO NTRK1 TAX1BP1 STK32B	1.39e-04	289	79	7	int:HLA-A
Interaction	OCLN interactions	ACE2 DPP4 FAM171A2 PCNX3 EGFR SLC19A1 APBB1 ZER1 PCNX1	1.46e-04	500	79	9	int:OCLN
Interaction	ATP5PD interactions	DPP4 EGFR SURF1 TAX1BP1 COX6B1 NIPSNAP2 UNC93B1	1.58e-04	295	79	7	int:ATP5PD
Interaction	ERO1A interactions	DPP4 FBXO6 EGFR PTPRO NTRK1	1.71e-04	132	79	5	int:ERO1A
Interaction	TTYH1 interactions	ATP8A1 PCNX3 SCD MACO1 ALG8 UNC93B1 ALG12	1.75e-04	300	79	7	int:TTYH1
Interaction	TELO2 interactions	ACE2 PTPRH EGFR NTRK1 UNC93B1	1.90e-04	135	79	5	int:TELO2
Interaction	ATAD3B interactions	ACE2 DPP4 FBXO6 EGFR SURF1 NTRK1	1.90e-04	213	79	6	int:ATAD3B
Interaction	COG7 interactions	EGFR NTRK1 TAX1BP1 UNC93B1	2.04e-04	74	79	4	int:COG7
Interaction	PBXIP1 interactions	ZDHHC15 DUOX1 NTRK1 MACO1 ALG8 UNC93B1	2.05e-04	216	79	6	int:PBXIP1
Interaction	ISYNA1 interactions	ACE2 ATP8A1 EGFR NTRK1	2.15e-04	75	79	4	int:ISYNA1
Interaction	SPNS1 interactions	ACE2 EGFR NTRK1 UNC93B1	2.15e-04	75	79	4	int:SPNS1
Interaction	CDH2 interactions	ACE2 DPP4 FBXO6 EGFR NTRK1	2.17e-04	139	79	5	int:CDH2
Interaction	SLC5A9 interactions	EGFR NTRK1	2.25e-04	6	79	2	int:SLC5A9
Interaction	NGLY1 interactions	FBXO6 PTPRH EGFR PTPRO	2.38e-04	77	79	4	int:NGLY1
Interaction	ABCC1 interactions	DPP4 SURF1 NTRK1 UNC93B1 STT3B	2.40e-04	142	79	5	int:ABCC1
Interaction	TM9SF3 interactions	ACE2 DPP4 EGFR SLC35E1 UNC93B1	2.48e-04	143	79	5	int:TM9SF3
Interaction	PHB2 interactions	ACE2 DPP4 EGFR SURF1 NTRK1 TAX1BP1 COX6B1 NIPSNAP2 UNC93B1	2.59e-04	540	79	9	int:PHB2
Interaction	COG1 interactions	EGFR NTRK1 UNC93B1 CHRM4	2.63e-04	79	79	4	int:COG1
Interaction	SEL1L interactions	FBXO6 EGFR PTPRO NTRK1 UNC93B1	2.64e-04	145	79	5	int:SEL1L
Interaction	XPO5 interactions	ACE2 DPP4 PTPRH EGFR NTRK1 UNC93B1	2.68e-04	227	79	6	int:XPO5
Interaction	MMP14 interactions	ACE2 FBXO6 PTPRH PTPRO	2.76e-04	80	79	4	int:MMP14
Interaction	TTC13 interactions	DPP4 FBXO6 EGFR PTPRO	2.76e-04	80	79	4	int:TTC13
Interaction	PTPRF interactions	ACE2 DPP4 FAM171A2 EGFR PTPRO NTRK1	3.08e-04	233	79	6	int:PTPRF
Interaction	ABCB7 interactions	EGFR SURF1 NTRK1 TAX1BP1 UNC93B1	3.09e-04	150	79	5	int:ABCB7
Interaction	ADCYAP1R1 interactions	ZDHHC15 ADCYAP1R1	3.15e-04	7	79	2	int:ADCYAP1R1
Interaction	AUP1 interactions	FBXO6 EGFR PTPRO NTRK1 UNC93B1 STT3B	3.15e-04	234	79	6	int:AUP1
Interaction	CLGN interactions	DPP4 MBTPS1 HLA-DMB PTPRO NTRK1 UNC93B1	3.22e-04	235	79	6	int:CLGN
Interaction	ERLIN2 interactions	ACE2 DPP4 FBXO6 NTRK1 TAX1BP1 UNC93B1	3.30e-04	236	79	6	int:ERLIN2
Interaction	LMAN1 interactions	DPP4 PTPRH PTPRO SLC19A1 NTRK1 MACO1 IFIT2 STT3B	3.31e-04	441	79	8	int:LMAN1
Interaction	PTPRH interactions	DOK1 PTPRH EGFR PTPRO	3.33e-04	84	79	4	int:PTPRH
Interaction	UNC5C interactions	ACE2 DPP4 NTRK1	3.77e-04	36	79	3	int:UNC5C
Interaction	GGH interactions	MBTPS1 FBXO6 EGFR NTRK1 MKLN1 UNC93B1	3.85e-04	243	79	6	int:GGH
Interaction	VDAC3 interactions	ACE2 DPP4 FBXO6 MRC2 NTRK1 UNC93B1 PQBP1	3.95e-04	343	79	7	int:VDAC3
Interaction	GJD3 interactions	EGFR SLC19A1 SCD MACO1 KIAA0319L SLC35E1 APBB1 STT3B	4.02e-04	454	79	8	int:GJD3
Interaction	SPTLC1 interactions	FBXO6 EGFR NTRK1 UNC93B1 STT3B	4.04e-04	159	79	5	int:SPTLC1
Interaction	IPO11 interactions	FBXO6 EGFR NTRK1 UNC93B1 CHRM4	4.04e-04	159	79	5	int:IPO11
Interaction	ATP1A1 interactions	ACE2 DPP4 SLC8A1 FBXO6 EGFR SCD NTRK1 NIPSNAP2 UNC93B1	4.10e-04	575	79	9	int:ATP1A1
Interaction	TM2D1 interactions	PCNX3 EGFR	4.18e-04	8	79	2	int:TM2D1
Interaction	ABCA4 interactions	ABCA4 ABCA13	4.18e-04	8	79	2	int:ABCA4
Interaction	TEC interactions	DOK1 EGFR NTRK1 IGSF9B	4.33e-04	90	79	4	int:TEC
Interaction	SLC1A5 interactions	ACE2 DPP4 FBXO6 EGFR NTRK1 UNC93B1	4.67e-04	252	79	6	int:SLC1A5
Interaction	BRAT1 interactions	NTRK1 TAX1BP1 NCBP1 CHRM4	5.10e-04	94	79	4	int:BRAT1
Interaction	CAND2 interactions	PTPRH EGFR UNC93B1 CHRM4	5.31e-04	95	79	4	int:CAND2
Interaction	RNMT interactions	ACE2 EGFR NTRK1 NCBP1	5.31e-04	95	79	4	int:RNMT
Interaction	MARCKS interactions	ACE2 FAM171A2 EGFR SLC19A1 NTRK1 MACO1 TAX1BP1 KIAA0319L STT3B	5.64e-04	601	79	9	int:MARCKS
Interaction	LONP1 interactions	ACE2 DPP4 EGFR NTRK1 MKLN1 NIPSNAP2 IFIT5 IFIT3	5.72e-04	479	79	8	int:LONP1
Interaction	DPM1 interactions	ACE2 FBXO6 EGFR NTRK1 UNC93B1	5.94e-04	173	79	5	int:DPM1
Interaction	GNAS interactions	ACE2 DPP4 EGFR NTRK1 TAX1BP1 ADCY5	5.97e-04	264	79	6	int:GNAS
Interaction	GORASP2 interactions	ACE2 DPP4 EGFR NTRK1 SLC35E1 IFIT5 ZER1	6.10e-04	369	79	7	int:GORASP2
Cytoband	7p12	EGFR NIPSNAP2	3.15e-06	2	82	2	7p12
Cytoband	2q24.3	DPP4 G6PC2	3.72e-04	16	82	2	2q24.3
Cytoband	10q23.31	IFIT5 IFIT2	1.70e-03	34	82	2	10q23.31
GeneFamily	Glucose 6-phosphatases, catalytic	G6PC2 G6PC1	2.24e-05	3	50	2	1074
GeneFamily	Cholinergic receptors muscarinic	CHRM2 CHRM4	7.46e-05	5	50	2	180
GeneFamily	Apolipoprotein B mRNA editing enzyme catalytic subunits	APOBEC3D APOBEC3C	4.86e-04	12	50	2	406
GeneFamily	ATP binding cassette subfamily A	ABCA4 ABCA13	6.68e-04	14	50	2	805
GeneFamily	Protein tyrosine phosphatases, receptor type	PTPRH PTPRO	1.52e-03	21	50	2	813
GeneFamily	Tetratricopeptide repeat domain containing\|Bardet-Biedl syndrome associated\|BBSome	IFIT5 IFIT2 IFIT3	3.95e-03	115	50	3	769
GeneFamily	Solute carriers	SLC6A18 SLC8A2 SLC8A1 SLC19A1 SLC35E1	4.59e-03	395	50	5	752
GeneFamily	X-linked mental retardation\|Angiotensin receptors	ZDHHC15 PQBP1	9.44e-03	53	50	2	103
GeneFamily	Fibronectin type III domain containing	PTPRH PTPRO IGSF9B	9.83e-03	160	50	3	555
GeneFamily	Immunoglobulin heavy locus at 14q32.33	IGHV5-51 IGHV4-38-2 IGHV4-59	1.49e-02	187	50	3	349
Coexpression	ERWIN_COHEN_BLOOD_TC_83_AGE_23_48YO_VACCINATED_VS_CONTROL_2DY_UP	FBXO6 KIAA0319L HELZ2 IFIT5 IFIT2 IFIT3	1.90e-06	119	81	6	M41139
Coexpression	BLANCO_MELO_COVID19_SARS_COV_2_LOW_MOI_INFECTION_A594_ACE2_EXPRESSING_CELLS_DN	DPP4 PSG5 ADCY5	1.01e-05	14	81	3	M34015
Coexpression	FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN	SLC8A1 HLA-DMB SLC35E1 IFIT5 FUCA1 APOBEC3C UNC93B1 IFIT2 IFIT3	1.20e-05	458	81	9	M4785
Coexpression	ZAK_PBMC_MRKAD5_HIV_1_GAG_POL_NEF_AGE_20_50YO_1DY_UP	DOK1 MFSD2A SLC8A1 FBXO6 HLA-DMB PTPRO KIAA0319L HELZ2 IFIT5 UNC93B1 IFIT2 LYST IFIT3	1.29e-05	1012	81	13	M40868
Coexpression	BLANCO_MELO_BRONCHIAL_EPITHELIAL_CELLS_INFLUENZA_A_DEL_NS1_INFECTION_UP	MFSD14A ACE2 DPP4 SLC8A2 FBXO6 HELZ2 IFIT5 UNC93B1 IFIT2 IFIT3	2.93e-05	644	81	10	M34026
Coexpression	GSE18791_UNSTIM_VS_NEWCATSLE_VIRUS_DC_6H_DN	CELA2A HELZ2 IFIT5 UNC93B1 IFIT2 IFIT3	3.21e-05	195	81	6	M4292
Coexpression	GAUCHER_PBMC_YF_VAX_STAMARIL_UNKNOWN_AGE_7DY_UP	FBXO6 KIAA0319L HELZ2 IFIT5 UNC93B1 IFIT2 IFIT3	3.41e-05	292	81	7	M41140
Coexpression	GSE27786_NKCELL_VS_ERYTHROBLAST_UP	MFSD14A FBXO6 ICMT SURF1 KIAA0319L UNC93B1	3.69e-05	200	81	6	M4853
Coexpression	MILI_PSEUDOPODIA_HAPTOTAXIS_DN	MFSD14A PCNX3 HLA-DMB ICMT SLC19A1 MRC2 SCD HELZ2 CTNS ALG12	4.68e-05	681	81	10	M5314
Coexpression	FRANCO_BLOOD_SANOFI_PASTEUR_SA_INACTIVATED_INFLUENZA_VACCINE_CORRELATED_WITH_ANTIBODY_RESPONSE_AGE_18_40YO_1DY_POSITIVE	FBXO6 PTPRO HELZ2 UNC93B1 IFIT3	5.07e-05	129	81	5	M41110
Coexpression	BEIER_GLIOMA_STEM_CELL_DN	FBXO6 HLA-DMB IFIT5 FUCA1	5.59e-05	67	81	4	M11720
Coexpression	MILI_PSEUDOPODIA_HAPTOTAXIS_DN	MFSD14A PCNX3 HLA-DMB ICMT SLC19A1 MRC2 SCD HELZ2 CTNS ALG12	6.11e-05	703	81	10	MM1055
Coexpression	GAUCHER_PBMC_YF_VAX_STAMARIL_UNKNOWN_AGE_3DY_UP	FBXO6 KIAA0319L HELZ2 IFIT5 IFIT2 IFIT3	6.12e-05	219	81	6	M41142
Coexpression	TRAVAGLINI_LUNG_SIGNALING_ALVEOLAR_EPITHELIAL_TYPE_2_CELL	DUOX1 ATP8A1 SCD PGC	7.02e-05	71	81	4	M41661
Coexpression	ERWIN_COHEN_BLOOD_VACCINE_TC_83_AGE_23_48YO_VACCINATED_VS_CONTROL_7DY_UP	FBXO6 IFIT5 IFIT2 IFIT3	7.42e-05	72	81	4	M41023
Coexpression	MOSERLE_IFNA_RESPONSE	IFIT5 IFIT2 IFIT3	1.20e-04	31	81	3	M3218
CoexpressionAtlas	kidney single cell_adult_RenalCortexMixed_StemCellamp_top-relative-expression-ranked_1000	SLC6A18 ATPSCKMT EPHX2 ACE2 MFSD2A SLC19A1 SURF1 TAX1BP1 RBPMS2 PTGR2 FUCA1 G6PC1 IFIT3	2.92e-05	887	81	13	gudmap_kidney single cell_adult_RenalCortexMixed_Scamp_1000
CoexpressionAtlas	kidney_adult_RenalCortexMixed_Std_top-relative-expression-ranked_500	SLC6A18 EPHX2 ACE2 DPP4 MFSD2A ABCA13 SCD G6PC1 IFIT3	3.40e-05	424	81	9	gudmap_kidney_adult_RenalCortexMixed_Std_500
CoexpressionAtlas	kidney_adult_JuxtaGlom_Ren1_top-relative-expression-ranked_1000	SLC6A18 EPHX2 ACE2 DPP4 SLC8A1 ABCA13 TMEM254 JPH2 PTGR2 FUCA1 G6PC1 IFIT3	4.83e-05	799	81	12	gudmap_kidney_adult_JuxtaGlom_Ren1_1000
CoexpressionAtlas	kidney single cell_adult_RenalCortexMixed_StemCellamp_k-means-cluster#1_top-relative-expression-ranked_1000	SLC6A18 ATPSCKMT EPHX2 ACE2 MFSD2A SLC19A1 SURF1 RBPMS2 PTGR2 FUCA1 G6PC1 IFIT3	7.04e-05	831	81	12	gudmap_kidney single cell_adult_RenalCortexMixed_Scamp_k1_1000
CoexpressionAtlas	kidney_adult_RenalCortexMixed_Std_top-relative-expression-ranked_1000	SLC6A18 EPHX2 ACE2 DPP4 MFSD2A ABCA13 SCD TMEM254 PTGR2 FUCA1 G6PC1 IFIT3	9.86e-05	861	81	12	gudmap_kidney_adult_RenalCortexMixed_Std_1000
ToppCell	COVID-19-Epithelial_cells-AT2\|COVID-19 / group, cell type (main and fine annotations)	DPP4 MFSD2A DUOX1 EGFR SCD PGC	1.08e-06	184	81	6	369b82f793deab672204558ae4e112cfa5aa9ccc
ToppCell	COVID-19-lung-AT2\|COVID-19 / Disease (COVID-19 only), tissue and cell type	DPP4 MFSD2A DUOX1 ATP8A1 SCD PGC	1.31e-06	190	81	6	27a1a86620fe9b5ee930d388b32352206485e6d0
ToppCell	COVID-19-lung-AT2\|lung / Disease (COVID-19 only), tissue and cell type	DPP4 MFSD2A DUOX1 ATP8A1 SCD PGC	1.35e-06	191	81	6	276455a64c2c3503d5048615762eb2ee37f0ac70
ToppCell	Mild/Remission-B_activate-7\|World / disease group and sub_cluster of B and Plasma cells(res = 0.5)	FBXO6 HELZ2 IFIT5 UNC93B1 IFIT2 IFIT3	1.35e-06	191	81	6	382686d62f7b8576c44bb9726a4e10dc26fd348e
ToppCell	Mild/Remission-B_activate-7\|Mild/Remission / disease group and sub_cluster of B and Plasma cells(res = 0.5)	FBXO6 HELZ2 IFIT5 UNC93B1 IFIT2 IFIT3	1.48e-06	194	81	6	01c97543972159a9468272da06e7e611e2c21fae
ToppCell	CV-Moderate-1\|Moderate / Virus stimulation, Condition and Cluster	FBXO6 HELZ2 IFIT5 IFIT2 LYST IFIT3	1.57e-06	196	81	6	b50cfcd87c5b67806450cb8b3c6860ab97f6d3b1
ToppCell	ASK440-Epithelial-Type_2\|ASK440 / Donor, Lineage and Cell class of Lung cells from Dropseq	DPP4 MFSD2A DUOX1 ATP8A1 SCD PGC	1.57e-06	196	81	6	754b4202b617165c6994a0b5a9b1e486dccdd44d
ToppCell	5'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.0.1\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	DPP4 MFSD2A DUOX1 ATP8A1 SCD PGC	1.57e-06	196	81	6	65e161fd672e37a5d10f28011bb422c4d7042d6a
ToppCell	CD8+_Memory_T_cell-CV-1\|CD8+_Memory_T_cell / cell class, Virus stimulation and cluster	FBXO6 HELZ2 IFIT5 IFIT2 LYST IFIT3	1.61e-06	197	81	6	e59b47bccc781b2117196fe322efa87559c237c6
ToppCell	ASK440-Epithelial-Type_2\|Epithelial / Donor, Lineage and Cell class of Lung cells from Dropseq	DPP4 MFSD2A DUOX1 ATP8A1 SCD PGC	1.61e-06	197	81	6	08d5bbeb77a4152af1c783bc958afcae24667767
ToppCell	CV-Severe-1\|CV / Virus stimulation, Condition and Cluster	FBXO6 SCD HELZ2 IFIT5 LYST IFIT3	1.66e-06	198	81	6	fc0e885e370ffb780eada62bb2b52065c2f8b26b
ToppCell	5'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.3.1\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	DPP4 MFSD2A DUOX1 ATP8A1 SCD PGC	1.71e-06	199	81	6	2dc33804f6691d7c9682e6c9b885e945fb97fc36
ToppCell	Parenchyma_COVID-19-Epithelial-TX-AT2-1\|Parenchyma_COVID-19 / Sample group, Lineage and Cell type	DPP4 MFSD2A DUOX1 ATP8A1 SCD PGC	1.76e-06	200	81	6	cf1991853e10c562edae9a0d71a209f35b07db80
ToppCell	Lung_Parenchyma-Severe-Epithelial-Epithelial-AT2-2\|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09)	DPP4 MFSD2A DUOX1 ATP8A1 SCD PGC	1.76e-06	200	81	6	acc771a902cf2f060c3eb9aedb72a256f5778a6c
ToppCell	Parenchyma_COVID-19-Epithelial-TX-AT2-2\|Parenchyma_COVID-19 / Sample group, Lineage and Cell type	DPP4 MFSD2A DUOX1 ATP8A1 SCD PGC	1.76e-06	200	81	6	ceb613ac6cdf0e3e6bb3f04d89034e18a524cefb
ToppCell	Lung_Parenchyma-Severe-Epithelial-Epithelial-AT2-1-\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	DPP4 MFSD2A DUOX1 ATP8A1 SCD PGC	1.76e-06	200	81	6	7618ae284625c5c121bcc00eb9f07e5b1e3adf23
ToppCell	Lung_Parenchyma-Severe-Epithelial-Epithelial-AT2-2-\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	DPP4 MFSD2A DUOX1 ATP8A1 SCD PGC	1.76e-06	200	81	6	eb44d1f80ecaac3a022cd04ab16dc36151e45488
ToppCell	Lung_Parenchyma-Severe-Epithelial-Epithelial-AT2-1\|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09)	DPP4 MFSD2A DUOX1 ATP8A1 SCD PGC	1.76e-06	200	81	6	23b319bf7e5ae03e5baa777c951da9bfc97cca8c
ToppCell	PBMC-Control-cDC_1\|Control / Compartment, Disease Groups and Clusters	TMEM232 HELZ2 IFIT5 IFIT2 IFIT3	9.74e-06	156	81	5	9b6c5bcac516a62bcc1f5be32ffa8c92735ef0bc
ToppCell	normal_Lymph_Node-Myeloid_cells-Pleural_Mac\|Myeloid_cells / Location, Cell class and cell subclass	PCNX3 NCBP1 CTNS IFIT2 IFIT3	1.35e-05	167	81	5	820472887f43b42ae7e44513ca3d5465fb4f71a7
ToppCell	facs-Thymus-Flowthrough-3m-Myeloid\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SLC8A1 HLA-DMB PTPRO SCD UNC93B1	1.56e-05	172	81	5	356a66cd9303470e427005cc67fdd22a2c4bf971
ToppCell	facs-Thymus-Flowthrough-3m-Myeloid-macrophage\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SLC8A1 HLA-DMB PTPRO SCD UNC93B1	1.56e-05	172	81	5	46fadeee483fdf8402df92ec98575a09c6c15b16
ToppCell	facs-Thymus-Flowthrough-3m-Myeloid-macrophage\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SLC8A1 HLA-DMB PTPRO SCD UNC93B1	1.56e-05	172	81	5	438d2e7f1897668a14d85ca70722e5d0102606dc
ToppCell	saliva-Severe-critical_progression_d28-40-Myeloid-Granulocytic-Neutrophil-Neu_c4-RSAD2\|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k)	MFSD14A IFIT5 UNC93B1 IFIT2 IFIT3	1.70e-05	175	81	5	97616bb5c127284aa9e67bc336dfcf29e137164b
ToppCell	facs-Marrow-B-cells-24m-Lymphocytic-naive_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HLA-DMB SCD CELA2A UNC93B1 G6PC2	1.70e-05	175	81	5	82482f3fc716701bed46dc65c2044577aed15427
ToppCell	facs-Marrow-B-cells-24m-Lymphocytic-naive_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HLA-DMB SCD CELA2A UNC93B1 G6PC2	1.70e-05	175	81	5	5092c5159f697e20bf8aa450c414ffd997738d25
ToppCell	facs-Marrow-B-cells-24m\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HLA-DMB SCD CELA2A G6PC2 SORCS1	1.70e-05	175	81	5	887e75fc90e59a6394d62f3c048a9cfdf6707725
ToppCell	facs-Heart-LA-24m-Lymphocytic-B_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HLA-DMB SCD CELA2A UNC93B1 PGC	1.74e-05	176	81	5	077f3fe5e3482ea3f639d789bd3d584161b36c02
ToppCell	facs-Heart-LA-24m-Lymphocytic-B_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HLA-DMB SCD CELA2A UNC93B1 PGC	1.74e-05	176	81	5	fc2ba468677b19b55130c1f06737f40300cd9d2e
ToppCell	facs-Heart-LV-3m-Mesenchymal-smooth_muscle_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SLC8A2 SLC8A1 RBPMS2 JPH2 ADCY5	1.89e-05	179	81	5	8da6863edc756540bb097cc7221c1408640d9bb4
ToppCell	facs-Heart-LV-3m-Mesenchymal-smooth_muscle_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SLC8A2 SLC8A1 RBPMS2 JPH2 ADCY5	1.89e-05	179	81	5	f39c13c99a07d009cc677e363ffe089089c64916
ToppCell	B_cells-ISG-high_B_cells\|World / Immune cells in Kidney/Urine in Lupus Nephritis	PTPRO HELZ2 IFIT5 IFIT2 IFIT3	2.10e-05	183	81	5	dc2b00e920efa1dcc2a6265cd1024e3249c9974f
ToppCell	368C-Myeloid-Macrophage-FABP4+_Macrophage_3\|368C / Donor, Lineage, Cell class and subclass (all cells)	HLA-DMB PTPRO SCD IFIT2 IFIT3	2.27e-05	186	81	5	ddfadd43efeac3b3e6b7062590cc2b8f2f2db2ab
ToppCell	3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.1.3\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	MFSD2A DUOX1 ATP8A1 SCD PGC	2.33e-05	187	81	5	7c44cec1c26ca5907a495f2d7e633410e2e9728f
ToppCell	Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2-D062\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	DPP4 MFSD2A DUOX1 ATP8A1 PGC	2.33e-05	187	81	5	5df9e1f5ca32217af255e76e6fb5afa346337811
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_1\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	ABCA4 FAM171A2 EGFR ABCA13 MRC2	2.33e-05	187	81	5	9225caf66e06ebe57e90d677122acb6498607f36
ToppCell	IPF-Epithelial-ATII\|Epithelial / Disease state, Lineage and Cell class	DPP4 MFSD2A ATP8A1 SCD PGC	2.39e-05	188	81	5	5f5fad2773e421760e67dbace23fd1f847a2e1e0
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	SLC8A1 RBPMS2 JPH2 IGSF9B ADCY5	2.45e-05	189	81	5	127ad2ba3e794df8cce2eee3e4171bccb5aad51b
ToppCell	5'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.3.2\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	MFSD2A DUOX1 MRC2 SCD PGC	2.45e-05	189	81	5	da014519d6eb21bc2dc2ed65eafe638b42a068ed
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	SLC8A1 RBPMS2 JPH2 IGSF9B ADCY5	2.45e-05	189	81	5	2cfb4d12f75678d1619f4743838a0e954bd57761
ToppCell	Calu_3-infected-SARSCoV2\|infected / Cell line, Condition and Strain	HELZ2 IFIT5 UNC93B1 IFIT2 IFIT3	2.58e-05	191	81	5	2da876d26f37a00dbdf1ee79d724306e8b20f304
ToppCell	wk_20-22-Hematologic-Myeloid-APOE+_Mac1\|wk_20-22 / Celltypes from embryonic and fetal-stage human lung	FBXO6 SCD SURF1 FUCA1 CTNS	2.58e-05	191	81	5	c204ec71b7755b46a18d3a6aa84d0f407145ce9d
ToppCell	CV-Healthy-1\|Healthy / Virus stimulation, Condition and Cluster	FBXO6 HELZ2 IFIT5 IFIT2 IFIT3	2.65e-05	192	81	5	2a2052b44e8f679ef484f03ba4fb37b0ec841b88
ToppCell	Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D062\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	DPP4 DUOX1 ATP8A1 KIAA0319L PGC	2.65e-05	192	81	5	29f49f00770c991b5f27e4cb701dd2d2d6cb7178
ToppCell	droplet-Heart-HEART_(LV+RV_ONLY)-30m-Mesenchymal-smooth_muscle_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ACE2 SLC8A2 RBPMS2 JPH2 ADCY5	2.71e-05	193	81	5	1043b28503bfaa0d5a82ec358bc86cbde73ea8f2
ToppCell	5'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.0.3\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	DPP4 MFSD2A DUOX1 SCD PGC	2.71e-05	193	81	5	8646e573f2d2ff175f3d02bfdf214e65f3b614d3
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	ABCA4 FAM171A2 EGFR ABCA13 MRC2	2.71e-05	193	81	5	0f2167eef8203a5659c8c72e4e77646003d64797
ToppCell	droplet-Heart-HEART_(LV+RV_ONLY)-30m-Mesenchymal-smooth_muscle_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ACE2 SLC8A2 RBPMS2 JPH2 ADCY5	2.71e-05	193	81	5	0266a4fdf436d83ec1d9392abba8c6ec5166970a
ToppCell	nucseq-Epithelial-Epithelial_Alveolar\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	MFSD2A DUOX1 ATP8A1 EGFR PGC	2.78e-05	194	81	5	53f3e49e91b1096f3226010e2de767efb490dfe4
ToppCell	critical-Myeloid-Monocyte-derived_Macrophage\|critical / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	SLC8A1 HELZ2 IFIT5 IFIT2 IFIT3	2.78e-05	194	81	5	e36d1fd141bdcbd9ed66a33de6cdfde77189a0c1
ToppCell	cellseq-Epithelial-Epithelial_Alveolar-AT2-AT2\|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	MFSD2A DUOX1 ATP8A1 SCD PGC	2.85e-05	195	81	5	6867f9c56ea27a17c8c4099aae0d79903c3748a5
ToppCell	3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.0.1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	MFSD2A DUOX1 ATP8A1 SCD PGC	2.85e-05	195	81	5	d9694db6bf239636d1335016878c98f6ee2eb0eb
ToppCell	COVID-19_Moderate-CD8+_T_activated\|World / disease group, cell group and cell class	FBXO6 HELZ2 IFIT5 IFIT2 IFIT3	2.85e-05	195	81	5	070c5d3bdbd4ea54a579c01c37fb99bcf823982e
ToppCell	cellseq-Epithelial-Epithelial_Alveolar-AT2\|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	MFSD2A DUOX1 ATP8A1 SCD PGC	2.85e-05	195	81	5	955a0a7244cd7eaf006a39e1bd03333baf6f30a4
ToppCell	Bronchial_Biopsy-Immune-Luminal_Macrophages\|Immune / Tissue, Lineage and Cell class of Lung Cells from 10X	PTPRO SCD FUCA1 IFIT2 IFIT3	2.85e-05	195	81	5	6800c17026ec6c56132bf4664b8fcd74d7836579
ToppCell	3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.3.1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	MFSD2A DUOX1 ATP8A1 MRC2 PGC	2.92e-05	196	81	5	7e5addaa844e66f8160e05858c341866a80aed23
ToppCell	mild-Myeloid-Neutrophils_2\|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs	KIAA0319L HELZ2 IFIT5 IFIT2 IFIT3	2.92e-05	196	81	5	ded44b38ea489946e9eedfe752b5a9fde9149c16
ToppCell	cellseq-Epithelial-Epithelial_Alveolar\|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	MFSD2A DUOX1 ATP8A1 SCD PGC	2.92e-05	196	81	5	a7cbe66ebd8931ef2b8ff26a42afce0ad1c48f17
ToppCell	Mild-CD8+_T_activated\|World / Disease group and Cell class	FBXO6 HELZ2 IFIT5 IFIT2 IFIT3	2.92e-05	196	81	5	79632190e44fcef9d7c11d9b9e37f2ebf0e6e255
ToppCell	3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.1.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	MFSD2A DUOX1 ATP8A1 SCD PGC	2.92e-05	196	81	5	83aeb96a33802949238d8a097086a1812201d1b5
ToppCell	Mild-CD4+_T_activated\|World / Disease group and Cell class	HELZ2 IFIT5 UNC93B1 IFIT2 IFIT3	2.92e-05	196	81	5	417b4fc2e4388f34c410576131b02936f93e46b6
ToppCell	CV-Moderate-1\|CV / Virus stimulation, Condition and Cluster	FBXO6 HELZ2 IFIT5 IFIT2 IFIT3	2.99e-05	197	81	5	e3d00d850b4d191f9592ef993c0eaadfe5710b5f
ToppCell	CV-Severe-1\|Severe / Virus stimulation, Condition and Cluster	FBXO6 HELZ2 IFIT5 IFIT2 IFIT3	3.07e-05	198	81	5	9b9ee0b0f6cc92e7be94869604c98f43d57ff8ff
ToppCell	367C-Epithelial_cells-Epithelial-E_(AT2)\|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells)	DPP4 MFSD2A ATP8A1 SCD PGC	3.07e-05	198	81	5	85215015bb86ada0e871c413a4ecdc903a3785ca
ToppCell	AT2_cells-Donor_03\|World / lung cells shred on cell class, cell subclass, sample id	MFSD2A DUOX1 EGFR SCD PGC	3.07e-05	198	81	5	893036558a9ad86b57f9e735df35812e9d18739e
ToppCell	Mild-CD8+_T_activated\|Mild / Disease group and Cell class	FBXO6 HELZ2 IFIT2 LYST IFIT3	3.07e-05	198	81	5	ceac1b51bacfd0dd7fe7c6a666f7927055e1f380
ToppCell	ASK428-Epithelial-Type_2\|ASK428 / Donor, Lineage and Cell class of Lung cells from Dropseq	MFSD2A DUOX1 ATP8A1 SCD PGC	3.07e-05	198	81	5	ec0d1801363adb70c6a26655b79d12b438c7417d
ToppCell	Tracheal-NucSeq-Stromal-Myofibroblastic\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	SLC8A1 JPH2 IGSF9B CHRM2 ADCY5	3.07e-05	198	81	5	c12e7511628db819a52959bb68580e27c00c2e41
ToppCell	CV-Mild-1\|CV / Virus stimulation, Condition and Cluster	FBXO6 HELZ2 IFIT5 IFIT2 IFIT3	3.07e-05	198	81	5	4b078714c49e7befb7b113d72485e712236d35fa
ToppCell	3'-Pediatric_IBD-SmallIntestine-Epithelial-mature_enterocytic-Enterocyte\|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract	EPHX2 ACE2 DPP4 PTPRH G6PC1	3.07e-05	198	81	5	c48b3f026b16d48b8eca9f74dc1e3f3f39a89322
ToppCell	Tracheal-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_airway_ASM\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	SLC8A1 JPH2 IGSF9B CHRM2 ADCY5	3.07e-05	198	81	5	22e766df1276c5b14aa0d83f434f47140ebb98ea
ToppCell	367C-Epithelial_cells-Epithelial-E_(AT2)-\|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells)	DPP4 MFSD2A ATP8A1 SCD PGC	3.07e-05	198	81	5	38349e42a3f1fb700ff6dfd89c4bf5ff97f1a3e9
ToppCell	Control-Control-Lymphocyte-T/NK-CD4+_T_activated\|Control / Disease, condition lineage and cell class	MRC2 HELZ2 IGHV4-59 IFIT2 IFIT3	3.07e-05	198	81	5	ee71543559836fd59adc0da877b2ca538cba60cb
ToppCell	Biopsy_Other_PF-Epithelial-AT2\|Biopsy_Other_PF / Sample group, Lineage and Cell type	DPP4 MFSD2A DUOX1 SCD PGC	3.14e-05	199	81	5	9a65acfe9bf500db72142469cf17bf0973540001
ToppCell	BAL-Severe-cDC_1\|Severe / Compartment, Disease Groups and Clusters	SLC8A1 HELZ2 UNC93B1 IFIT2 IFIT3	3.14e-05	199	81	5	9f5750212b887f92761ade33fc6e108cd5275297
ToppCell	control-CD163+_Monocytes_(Sample_ID1_d7)\|control / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	HLA-DMB HELZ2 UNC93B1 IFIT2 IFIT3	3.14e-05	199	81	5	933201d32eda12a89660bdbae9114a95cc428a38
ToppCell	BAL-Mild-cDC_1\|Mild / Compartment, Disease Groups and Clusters	SLC8A1 HELZ2 UNC93B1 IFIT2 IFIT3	3.14e-05	199	81	5	c55181bdec8952b54198f0d4c9c5c84265b16572
ToppCell	Biopsy_IPF-Epithelial-AT2\|Biopsy_IPF / Sample group, Lineage and Cell type	DPP4 MFSD2A DUOX1 SCD PGC	3.14e-05	199	81	5	c841d475703d3489161fb7904526bd7563d5fb0f
ToppCell	Transplant_Alveoli_and_parenchyma-Epithelial-Type_2_alveolar\|Transplant_Alveoli_and_parenchyma / Tissue, Lineage and Cell class of Lung Cells from 10X	MFSD2A DUOX1 ATP8A1 SCD PGC	3.14e-05	199	81	5	e28ace2ca680c6154398e17110aa1838dd7a5548
ToppCell	proximal-Epithelial-Signaling_Alveolar_Epithelial_Type_2-3\|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	MFSD2A DUOX1 ATP8A1 SCD PGC	3.22e-05	200	81	5	7bd76884fcffdbd9b8d24f5b6b5187ad3963da5f
ToppCell	Sepsis-Leuk-UTI\|Sepsis / Disease, condition lineage and cell class	ZDHHC15 CFAP251 HLA-DMB IFIT2 IFIT3	3.22e-05	200	81	5	7d92b24c0c888dd46e40b7e3c6c2645c3604f132
ToppCell	proximal-Epithelial-Signaling_Alveolar_Epithelial_Type_2\|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	MFSD2A DUOX1 ATP8A1 SCD PGC	3.22e-05	200	81	5	af57f837eb7f988d24fc4612d16d68121498f0b0
ToppCell	proximal-3-Epithelial-Signaling_Alveolar_Epithelial_Type_2\|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	MFSD2A DUOX1 ATP8A1 SCD PGC	3.22e-05	200	81	5	9c7859659843b1566bdf623b269b5e166c89d38c
ToppCell	frontal_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Tac2_Tacstd2\|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	EPHX2 STK32B IFIT2 IFIT3	6.61e-05	119	81	4	e868453c02dcf0e07821886b81ca739887d43c67
ToppCell	PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Myeloid-Granulocytic-Neutrophil-Neu_c5-GSTP1(high)OASL(low)\|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k)	PTPRO IFIT5 IFIT2 IFIT3	9.05e-05	129	81	4	e50bd63ad8035abf5135d7d2cb8636206d6e69a5
ToppCell	frontal_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Tac2_Myh4\|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	EPHX2 STK32B IFIT2 IFIT3	9.05e-05	129	81	4	f83187c0bb06528127b8d2d56674ab1946846951
ToppCell	TCGA-Bone_and_Soft_Tissue-Primary_Tumor-Sarcoma-Undifferentiated_Pleomorphic_Sarcoma-4\|TCGA-Bone_and_Soft_Tissue / Sample_Type by Project: Shred V9	PTPRH TAX1BP1 STK32B CTNS	9.60e-05	131	81	4	2ccf679b5035b7b9cdb9a9a660cad90288592187
ToppCell	facs-Heart-Unknown-3m-Endothelial-endothelial_cell_of_coronary_artery\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ACE2 ABCA4 G6PC1 SORCS1	1.28e-04	141	81	4	4aa4b3476dc5abefbd348353cfe711cd5fe3d52f
ToppCell	facs-Heart-Unknown-3m-Endothelial-coronary_vascular_endothelial_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ACE2 ABCA4 G6PC1 SORCS1	1.28e-04	141	81	4	e40c6f1b7fbaa46b3eaa55f1b37ef360b04370a8
ToppCell	saliva-Severe-critical_progression_d12-22_no-steroids-Myeloid-Granulocytic-Neutrophil-Neu_c4-RSAD2\|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)	PSG5 IFIT5 IFIT2 IFIT3	1.28e-04	141	81	4	b5e85f89b930a0ec70cc95733c5ab76ac3e9497f
ToppCell	primary_visual_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Tac2_Tacstd2\|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	EPHX2 STK32B IFIT2 IFIT3	1.35e-04	143	81	4	24fd24846fbef049af669a57d42fcc18928d2b27
ToppCell	droplet-Liver-hepatocytes-3m-Epithelial-Hepatocyte_(Pericentral_and_Periportal)\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	EPHX2 EGFR SCD G6PC1	1.50e-04	147	81	4	00619115b9a1ec2b967c2992043b41974ece63c4
ToppCell	Lymphoid-Lymphoid-B_cells\|Lymphoid / shred on cell class and cell subclass (v4)	HLA-DMB SCD MACO1 UNC93B1	1.62e-04	150	81	4	5ebf6b4b9b029422a4676ba09a6a9225bd25db47
ToppCell	Frontal_cortex-Endothelial-MURAL-M1(Rgs5Acta2)\|Frontal_cortex / BrainAtlas - Mouse McCarroll V32	ACE2 SLC19A1 RBPMS2 JPH2	1.66e-04	151	81	4	527059e47e381b2f6d63c1abb39bc0795ee3829d
ToppCell	Frontal_cortex-Endothelial-MURAL\|Frontal_cortex / BrainAtlas - Mouse McCarroll V32	ACE2 SLC19A1 RBPMS2 JPH2	1.66e-04	151	81	4	7570372a315bc312ff57bb5f483375c401ae8787
ToppCell	COVID-19_Mild\|World / 5 Neutrophil clusters in COVID-19 patients	MFSD14A PCNX1 IFIT2 IFIT3	1.70e-04	152	81	4	2ff0980dfd8d430cca14649151d856edef115720
ToppCell	MS-CD4-antiviral_CD4\|MS / Condition, Cell_class and T cell subcluster	HELZ2 IFIT5 IFIT2 IFIT3	1.70e-04	152	81	4	b1eba2d5a6da3eeb83d40a92976e3e8751ed18ee
ToppCell	NS-critical-d_16-33-Myeloid-Monocyte-derived_Macrophage\|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	HELZ2 IFIT5 IFIT2 IFIT3	1.75e-04	153	81	4	859de35b24c5d7d73be1c213b90b43362ee2e0eb
ToppCell	LPS-IL1RA+antiTNF-Unknown-Endothelial-Myofibroblast\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	DOK1 SLC8A1 IFIT5 ALG12	1.79e-04	154	81	4	16fdafb5c64d2db321554f87129a962d113f1668
ToppCell	lymphoid-T_cell-pro-T_cell\|T_cell / Lineage, cell class and subclass	PCNX3 IFIT2 IFIT3 SORCS1	2.07e-04	160	81	4	66fe86d2f37983761141e5bb3de127f0b4bb0951
Computational	Genes upregulated in subsets of cells of a given type within various tumors	MFSD2A DUOX1 SCD PGC	1.03e-04	50	53	4	GAVISH_3CA_MALIGNANT_METAPROGRAM_31_ALVEOLAR
Drug	Mebeverine hydrochloride [2753-45-9]; Up 200; 8.6uM; MCF7; HT_HG-U133A	DOK1 EPHX2 EGFR MRC2 KIAA0319L NCBP1 APOBEC3C	5.97e-06	199	79	7	6795_UP
Drug	phlorobenzophenone	ICMT LYST	1.19e-05	2	79	2	CID000077093
Drug	himbacine	CHRM2 CHRM4	1.19e-05	2	79	2	ctd:C048172
Drug	14,15-eicosa-5-enoic acid	EPHX2 EGFR	1.19e-05	2	79	2	ctd:C494022
Drug	epicholesterol	EPHX2 MBTPS1 ABCA4 EGFR SCD TAX1BP1 G6PC2 CHRM2 LYST G6PC1 ADCY5	1.20e-05	636	79	11	CID000000304
Drug	NSC236997	ACE2 DPP4 DUOX1 EGFR PTPRO SCD NTRK1 LYST G6PC1 ADCY5	1.69e-05	539	79	10	CID000005300
Drug	H S Q	MBTPS1 SPAM1 MRC2 ALG8 FUCA1 IFIT3 ALG12 STT3B	2.97e-05	351	79	8	CID000000897
Drug	Amitriptyline	NTRK1 CHRM2 CHRM4	3.16e-05	18	79	3	DB00321
Drug	UNC 0638	IFIT2 CHRM2 IFIT3	3.16e-05	18	79	3	ctd:C561310
Drug	Cinnamylbenzene	EPHX2 ICMT	3.56e-05	3	79	2	CID000099034
Drug	eburnamonine	CHRM2 CHRM4	3.56e-05	3	79	2	ctd:C016422
Drug	Bepridil hydrochloride [74764-40-2]; Up 200; 10uM; MCF7; HT_HG-U133A	DUOX1 SLC8A1 EGFR PCNX1 IFIT2 IFIT3	5.23e-05	190	79	6	5674_UP
Drug	Ticlopidine hydrochloride [53885-35-1]; Up 200; 13.4uM; MCF7; HT_HG-U133A	DOK1 NTRK1 APOBEC3C IFIT2 CHRM4 IFIT3	5.23e-05	190	79	6	4155_UP
Drug	Tiapride hydrochloride [51012-33-0]; Down 200; 11uM; PC3; HT_HG-U133A	MBTPS1 SLC19A1 MACO1 APBB1 CTNS IFIT2	6.04e-05	195	79	6	3663_DN
Drug	LY294002; Up 200; 10uM; PC3; HG-U133A	DPP4 MBTPS1 SLC8A1 SPAM1 ZER1 CHRM4	6.04e-05	195	79	6	429_UP
Drug	Penbutolol sulfate [38363-32-5]; Down 200; 5.8uM; MCF7; HT_HG-U133A	SLC19A1 KIAA0319L SLC35E1 PCNX1 LYST ALG12	6.22e-05	196	79	6	3534_DN
Drug	Trimipramine maleate salt [521-78-8]; Down 200; 9.8uM; MCF7; HT_HG-U133A	DOK1 TAX1BP1 ZER1 PCNX1 LYST ALG12	6.22e-05	196	79	6	3342_DN
Drug	tetraethylenepentamine pentahydrochloride; Up 200; 100uM; ssMCF7; HG-U133A	ACE2 MRC2 MACO1 PCNX1 IFIT2 CARD8	6.40e-05	197	79	6	498_UP
Drug	Fursultiamine Hydrochloride [2105-43-3]; Down 200; 9.2uM; PC3; HT_HG-U133A	EGFR MRC2 ZER1 PCNX1 CTNS ALG12	6.58e-05	198	79	6	6630_DN
Drug	Carteolol hydrochloride [51781-21-6]; Down 200; 12.2uM; HL60; HT_HG-U133A	DOK1 PTPRO SLC19A1 TMEM254 APOBEC3C LYST	6.58e-05	198	79	6	1340_DN
Drug	Zardaverine [101975-10-4]; Down 200; 15uM; PC3; HT_HG-U133A	DPP4 PTPRH ZER1 RS1 IFIT2 ALG12	6.76e-05	199	79	6	4209_DN
Drug	furtrethonium	CHRM2 CHRM4	7.10e-05	4	79	2	ctd:C028530
Drug	Hyoscyamine	CHRM2 CHRM4	7.10e-05	4	79	2	DB00424
Drug	Procyclidine	CHRM2 CHRM4	7.10e-05	4	79	2	DB00387
Drug	Tropicamide	CHRM2 CHRM4	7.10e-05	4	79	2	DB00809
Drug	5-methylfurtrethonium	CHRM2 CHRM4	7.10e-05	4	79	2	ctd:C008446
Drug	quingestanol acetate	APOBEC3C G6PC1	7.10e-05	4	79	2	CID000018142
Drug	5-nitrosalicylaldehyde	DPP4 G6PC2 G6PC1	8.75e-05	25	79	3	CID000066808
Drug	Atropine	CHRM2 CHRM4	1.18e-04	5	79	2	DB00572
Drug	Darifenacin	CHRM2 CHRM4	1.18e-04	5	79	2	DB00496
Drug	Metixene	CHRM2 CHRM4	1.18e-04	5	79	2	DB00340
Drug	Trihexyphenidyl	CHRM2 CHRM4	1.18e-04	5	79	2	DB00376
Drug	Solifenacin	CHRM2 CHRM4	1.18e-04	5	79	2	DB01591
Drug	5-(3-(3-hydroxyphenoxy)azetidin-1-yl)-5-methyl-2,2-diphenylhexanamide	CHRM2 CHRM4	1.18e-04	5	79	2	ctd:C568516
Drug	xanomeline	CHRM2 CHRM4	1.18e-04	5	79	2	ctd:C075257
Drug	Pipecuronium	CHRM2 CHRM4	1.18e-04	5	79	2	ctd:D017300
Drug	N-Methylscopolamine	CHRM2 CHRM4	1.18e-04	5	79	2	ctd:D019832
Drug	Cryptenamine	CHRM2 CHRM4	1.18e-04	5	79	2	DB00785
Drug	Homatropine Methylbromide	CHRM2 CHRM4	1.18e-04	5	79	2	DB00725
Drug	Fesoterodine	CHRM2 CHRM4	1.18e-04	5	79	2	DB06702
Drug	Scopolamine Derivatives	CHRM2 CHRM4	1.18e-04	5	79	2	ctd:D012602
Drug	Tolterodine	CHRM2 CHRM4	1.18e-04	5	79	2	DB01036
Drug	Quinuclidinyl Benzilate	CHRM2 CHRM4	1.18e-04	5	79	2	ctd:D011813
Drug	Gallamine Triethiodide	CHRM2 CHRM4	1.77e-04	6	79	2	ctd:D005703
Drug	acetone hydrazone	ACE2 EGFR	1.77e-04	6	79	2	CID000078937
Drug	AC1Q5R6K	ACE2 PGC	1.77e-04	6	79	2	CID000114973
Drug	Brompheniramine	CHRM2 CHRM4	1.77e-04	6	79	2	DB00835
Drug	Benzquinamide	CHRM2 CHRM4	1.77e-04	6	79	2	DB00767
Drug	Scopolamine	CHRM2 CHRM4	1.77e-04	6	79	2	DB00747
Drug	Crotalid Venoms	CHRM2 CHRM4	1.77e-04	6	79	2	ctd:D003435
Drug	2-mercaptonicotinic acid	G6PC2 G6PC1	1.77e-04	6	79	2	CID000673681
Drug	brucine N-oxide	CHRM2 CHRM4	1.77e-04	6	79	2	ctd:C083067
Disease	PR interval	MFSD2A SLC8A1 PCNX3 RBPMS2 MKLN1 CHRM2 ADCY5	2.89e-04	495	76	7	EFO_0004462
Disease	Influenza	IFIT5 IFIT2 IFIT3	3.31e-04	52	76	3	C0021400
Disease	Animal Mammary Neoplasms	EGFR MRC2 SCD ADCY5	5.04e-04	142	76	4	C0024667
Disease	Mammary Carcinoma, Animal	EGFR MRC2 SCD ADCY5	5.04e-04	142	76	4	C1257925
Disease	congenital disorder of glycosylation type I (implicated_via_orthology)	ALG8 ALG12	6.73e-04	15	76	2	DOID:0050570 (implicated_via_orthology)
Disease	Mammary Neoplasms, Experimental	EGFR MRC2 SCD ADCY5	7.00e-04	155	76	4	C0024668
Disease	Carcinomatosis	EGFR MRC2 SCD ADCY5	8.45e-04	163	76	4	C0205699
Disease	Carcinoma, Spindle-Cell	EGFR MRC2 SCD ADCY5	8.45e-04	163	76	4	C0205697
Disease	Undifferentiated carcinoma	EGFR MRC2 SCD ADCY5	8.45e-04	163	76	4	C0205698
Disease	Anaplastic carcinoma	EGFR MRC2 SCD ADCY5	8.45e-04	163	76	4	C0205696
Disease	Carcinoma	EGFR MRC2 SCD ADCY5	8.65e-04	164	76	4	C0007097
Disease	glaucoma (implicated_via_orthology)	ACE2 NTRK1	8.68e-04	17	76	2	DOID:1686 (implicated_via_orthology)
Disease	Intellectual Disability	ACE2 MFSD2A SURF1 FUCA1 PQBP1 STT3B	1.04e-03	447	76	6	C3714756
Disease	cytochrome-c oxidase deficiency disease (is_implicated_in)	SURF1 COX6B1	1.09e-03	19	76	2	DOID:3762 (is_implicated_in)
Disease	Hypertensive disease	SLC6A18 ACE2 CELA2A ADCY5	1.49e-03	190	76	4	C0020538
Disease	BMI-adjusted fasting blood glucose measurement	G6PC2 ADCY5	1.60e-03	23	76	2	EFO_0008036
Disease	Cytochrome-c Oxidase Deficiency	SURF1 COX6B1	1.74e-03	24	76	2	C0268237
Disease	FEV change measurement, response to zileuton	EPHX2 PCNX1	1.89e-03	25	76	2	EFO_0005921, EFO_0007676

Protein segments in the cluster

Peptide	Gene	Start	Entry
PDTVWSIGYWLCYVN	CHRM4	431	P08173
LSPNTNYEVTWYTSW	APOBEC3D	276	Q96AK3
SGVSPTTYWVTNFLW	ABCA4	1716	P78363
SPNTKYQVTWYTSWS	APOBEC3C	81	Q9NRW3
PWYFPFTASYWKSVG	ABCA13	3786	Q86UQ4
VWTIGYWLCYINSTI	CHRM2	421	P08172
SGTYYWHIPTGTTQW	APBB1	266	O00213
PWQVSLQYSSNGKWY	CELA2A	41	P08217
SEGIWWTVFFIYTIY	ADCY5	326	O95622
YWAGWYGPRVTNSSI	FBXO6	241	Q9NRD1
ALWVVFFGIYSSLWP	ATP8A1	1016	Q9Y2Q0
KSSNWGTSPLLWYFY	ALG12	251	Q9BV10
MTWSFGWNSSLPVYY	CFAP251	251	Q8TBY9
TSYPVSWSSVIGVWY	CRISP1	106	P54107
RWYPSSDTTQQGWKY	RBPMS2	191	Q6ZRY4
YPCTLVGTWNTWYGE	NIPSNAP2	106	O75323
KYYWWFFQTVPGLTG	DUOX1	1181	Q9NRD9
VLWEIFTYGKQPWYQ	NTRK1	716	P04629
VYTWPSGNTFEGYWS	JPH2	51	Q9BR39
RDWYVYAFLSSLPWV	NCBP1	166	Q09161
YSSVLWPWSGYLAIS	MBTPS1	551	Q14703
PASWILSGYYWQTSA	KIAA0319L	11	Q8IZA0
PIQWLFFAASTYVWV	MACO1	96	Q8N5G2
FVYTYIAPWQITWGS	PCNX1	1456	Q96RV3
LTYIAPWQITWGSAF	PCNX3	1246	Q9H6A9
PDTYWNSTNFLSWLY	FUCA1	236	P04066
YSWVSEEPLNYVGWQ	MRC2	1196	Q9UBG0
YSALWWSPNGTFLAY	DPP4	211	P27487
HLSSDGTYFYWIWSP	HECTD4	16	Q9Y4D8
GTYFYWIWSPASLNE	HECTD4	21	Q9Y4D8
GSISSYYWSWIRQPP	IGHV4-59	46	P01825
YSISSGYYWGWIRQP	IGHV4-38-2	46	P0DP08
ISPWWYFAVISVSGV	MFSD14A	121	Q96MC6
FYWYTIIGWGTPTVC	ADCYAP1R1	266	P41586
YSFTSYWIGWVRQMP	IGHV5-51	46	A0A0C4DH38
LWTDYLLAFYINPWS	PTPRO	891	Q16827
QLYWTFVSPQLGYWV	FAM171A2	276	A8MVW0
IWFVPDFPHGQTYWY	MFSD2A	146	Q8NA29
GLPYYWNADTDLVSW	PQBP1	61	O60828
YTHQSDVWSYGVTVW	EGFR	891	P00533
YVWGFYPAEVTITWR	HLA-DMB	136	P28068
PSYVGWFYWSIGTQV	ICMT	211	O60725
GFPESWYSWRYQIPA	EPHX2	266	P34913
VRSLVTWGNYAWVYY	IFIT5	91	Q13325
YSPTWEGSQFWVTVQ	DOK1	146	Q99704
GQRPYWWVLDTDYYS	G6PC1	81	P35575
WWVLDTDYYSNTSVP	G6PC1	86	P35575
IRSLVTWGNYAWVYY	IFIT3	91	O14879
STNRYSVWFPTAGWY	CARD8	176	Q9Y2G2
WGRFWTNLYSLTVPF	ACE2	271	Q9BYF1
FGHRPYWWVQETQIY	G6PC2	76	Q9NQR9
VWYDPIYYPTSWQLD	LYST	2936	Q99698
IRSLVTWGNYAWVYY	IFIT2	91	P09913
WLWNESTALYPSIYL	SPAM1	251	P38567
GWIYFVAWSISFYPQ	CTNS	131	O60931
YSLQVDWYTWATSPI	HELZ2	1661	Q9BYK8
WYQRVYQSLCPTSWV	COX6B1	56	P14854
GWSTARDYYTFLWSP	TAX1BP1	56	Q86VP1
LLSWGPSFNFSIWYV	MKLN1	136	Q9UL63
VTWYGLSAATSYLWF	SURF1	276	Q15526
FLVSSDLTYVYQWPW	SLC35E1	246	Q96K37
ISLYYNTIVAWVLWY	SLC6A18	111	Q96N87
FTAVGYELNPWLVWY	ATPSCKMT	111	Q6P4H8
PISQWYYEATSEWTL	ALG8	51	Q9BVK2
VLDPSGDYYYWWLNT	CNGA4	26	Q8IV77
QLGPTEASYYWVYWV	UBFD1	276	O14562
WATWALYNLVSVYPD	ZER1	701	Q7Z7L7
WWQAVAIFTVYLGSS	UNC93B1	476	Q9H1C4
TGQIYWAPVTQELYW	PGC	236	P20142
RAEAYPGNLTYTWYW	IGSF9B	251	Q9UPX0
FSWAWNVVYIYTVIL	TMEM232	351	C9JQI7
YIAPWSGRFYSLWDT	STT3B	376	Q8TCJ2
SLWWVFNSAGYYLVV	SLC19A1	271	P41440
TLVPWYFWGETFQNS	SCD	231	O00767
GYSYPVDWWSLGITA	STK32B	201	Q9NY57
PEQYVGWYSSWTANK	RS1	86	O15537
LTYVWWYGNNTEPLI	SORCS1	921	Q8WY21
ITLSFGYYTWVVFWP	TMEM254	21	Q8TBM7
GYYTWVVFWPQSIPY	TMEM254	26	Q8TBM7
YTYIWWLNGQSLPVS	PSG5	176	Q15238
PGQSSYSYWVSWVRE	PTPRH	501	Q9HD43
TKGDFVTSFYWPWQT	PTGR2	91	Q8N8N7
VFFTWTYWKSIFTLP	ZDHHC15	66	Q96MV8
VTAAWSIFAYTWLYI	SLC8A1	206	P32418
TASWSIFAYVWLYLI	SLC8A2	201	Q9UPR5